JELD-WEN HOLDING, INC., 10-Q filed on 5/5/2026
Quarterly Report
v3.26.1
COVER - shares
 3 Months Ended
Mar. 28, 2026
May 01, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 28, 2026  
Document Transition Report false  
Entity File Number 001-38000  
Entity Registrant Name JELD-WEN Holding, Inc.  
Entity Incorporation, State DE  
Entity Tax Identification Number 93-1273278  
Entity Address, Street Name 2645 Silver Crescent Drive  
Entity Address, City Charlotte  
Entity Address, State NC  
Entity Address, Postal Zip Code 28273  
City Area Code 704  
Local Phone Number 378-5700  
Title of each class Common Stock (par value $0.01 per share)  
Trading Symbol JELD  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   86,151,321
Entity Central Index Key 0001674335  
Amendment Flag false  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Current Fiscal Year End Date --12-31  
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Income Statement [Abstract]    
Net revenues $ 722,125 $ 776,006
Cost of sales 629,411 663,923
Gross margin 92,714 112,083
Selling, general and administrative 145,957 144,767
Goodwill impairment (Note 6) 0 137,721
Restructuring and asset-related charges, net (Note 16) 1,979 14,546
Operating loss (55,222) (184,951)
Interest expense, net 17,203 14,918
Loss on extinguishment and refinancing of debt (Note 10) 0 237
Other expense (income) (Note 17) 1,043 (10,586)
Loss before taxes (73,468) (189,520)
Income tax expense (Note 11) 3,376 618
Net loss $ (76,844) $ (190,138)
Weighted average common shares outstanding (Note 14)    
Basic (in shares) 85,803,503 84,917,294
Diluted (in shares) 85,803,503 84,917,294
Net loss per share    
Basic (usd per share) $ (0.90) $ (2.24)
Diluted (usd per share) $ (0.90) $ (2.24)
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Statement of Comprehensive Income [Abstract]    
Net loss $ (76,844) $ (190,138)
Other comprehensive (loss) income, net of tax:    
Foreign currency translation adjustments (6,689) 20,813
Foreign currency hedge adjustments, net of tax expense (benefit) of $23 and $(597), respectively. 84 (1,300)
Interest rate hedge adjustments, net of tax benefit of $0 and $(12), respectively. 41 (35)
Commodity hedge adjustments, net of tax expense of $0 and $51, respectively. 0 149
Defined benefit pension plans, net of tax expense (benefit) of $4 and $(9), respectively. 10 (19)
Total other comprehensive (loss) income, net of tax (6,554) 19,608
Comprehensive loss $ (83,398) $ (170,530)
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Statement of Comprehensive Income [Abstract]    
Net investment hedge adjustments, net of tax expense (benefit) $ 23 $ (597)
Interest rate hedge adjustments, net of tax benefit 0 (12)
Commodity hedge adjustments, net of tax expense 0 51
Defined benefit pension plans, net of tax expense (benefit) $ 4 $ (9)
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Mar. 28, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 50,361 $ 136,103
Restricted cash 1,986 2,145
Accounts receivable, net (Note 3) 428,119 361,192
Inventories (Note 4) 446,191 444,102
Other current assets 69,044 73,202
Total current assets 995,701 1,016,744
Property and equipment, net (Note 5) 724,287 728,445
Deferred tax assets 15,954 16,289
Intangible assets, net (Note 7) 93,092 96,330
Operating lease assets, net 183,590 179,378
Other assets 64,644 65,628
Total assets 2,077,268 2,102,814
Current liabilities    
Accounts payable 267,503 237,280
Accrued payroll and benefits 86,791 93,827
Accrued expenses and other current liabilities (Note 8) 218,247 223,147
Current maturities of long-term debt (Note 10) 19,526 23,690
Total current liabilities 592,067 577,944
Long-term debt (Note 10) 1,189,436 1,149,614
Unfunded pension liability 24,048 24,357
Operating lease liability 160,907 158,565
Deferred credits and other liabilities 84,024 85,424
Deferred tax liabilities 14,605 14,694
Total liabilities 2,065,087 2,010,598
Commitments and contingencies (Note 20)
Shareholders’ equity    
Preferred Stock, par value $0.01 per share, 90,000,000 shares authorized; no shares issued and outstanding 0 0
Common Stock: 900,000,000 shares authorized, par value $0.01 per share, 86,120,743 and 85,489,683 shares issued and outstanding, respectively 860 854
Additional paid-in capital 786,672 783,315
Accumulated deficit (718,406) (641,562)
Accumulated other comprehensive loss (56,945) (50,391)
Total shareholders’ equity 12,181 92,216
Total liabilities and shareholders’ equity $ 2,077,268 $ 2,102,814
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Mar. 28, 2026
Dec. 31, 2025
Statement of Financial Position [Abstract]    
Preferred stock, par value (usd per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 90,000,000 90,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock authorized (in shares) 900,000,000 900,000,000
Common stock, par value (usd per share) $ 0.01 $ 0.01
Common stock, shares issued (in shares) 86,120,743 85,489,683
Common stock, shares outstanding (in shares) 86,120,743 85,489,683
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Preferred stock
Common stock
Additional paid-in capital
Other additional paid in capital
Other additional paid in capital
Employee stock notes
(Accumulated deficit) retained earnings
Accumulated other comprehensive loss
Foreign currency adjustments
Unrealized gain on foreign currency hedges, net of tax
Unrealized gain (loss) on interest rate hedges, net of tax
Net actuarial pension loss, net of tax
Balance at beginning of period at Dec. 31, 2024     $ 846   $ 769,737 $ (673) $ (20,353) $ (129,495)        
Balance at beginning of period (in shares) at Dec. 31, 2024     84,653,408                  
Increase (Decrease) in Stockholders' Equity                        
Shares issued for exercise/vesting of share-based compensation awards (in shares)     619,074                  
Shares issued for exercise/vesting of share-based compensation awards     $ 6   (4)              
Shares surrendered for tax obligations for employee share-based transactions (in shares)     (55,057)                  
Shares surrendered for tax obligations for employee share-based transactions     $ (1)   (622)              
Amortization of share-based compensation         3,228              
Net loss $ (190,138)           (190,138)          
Foreign currency adjustments 20,813               $ 20,813      
Unrealized gain (loss) on foreign currency hedges, net of tax                   $ (1,300)    
Unrealized gain (loss) on interest rate hedges, net of tax                     $ (35)  
Unrealized gain on commodity hedges, net of tax                     149  
Net actuarial pension gain (loss), net of tax (19)                     $ (19)
Balance at period end (in shares) at Mar. 29, 2025   0                    
Balance at end of period at Mar. 29, 2025 $ 452,139 $ 0 $ 851 $ 771,666 772,339 (673) (210,491) (109,887)        
Balance at period end (in shares) at Mar. 29, 2025     85,217,425                  
Balance at beginning of period (in shares) at Dec. 31, 2025 0                      
Balance at beginning of period at Dec. 31, 2025 $ 92,216   $ 854   783,988 (673) (641,562) (50,391)        
Balance at beginning of period (in shares) at Dec. 31, 2025 85,489,683   85,489,683                  
Increase (Decrease) in Stockholders' Equity                        
Shares issued for exercise/vesting of share-based compensation awards (in shares)     714,885                  
Shares issued for exercise/vesting of share-based compensation awards     $ 7   (5)              
Shares surrendered for tax obligations for employee share-based transactions (in shares)     (83,825)                  
Shares surrendered for tax obligations for employee share-based transactions     $ (1)   (230)              
Reclassification of share-based awards to liability         (90)              
Amortization of share-based compensation         3,682              
Net loss $ (76,844)           (76,844)          
Foreign currency adjustments (6,689)               $ (6,689)      
Unrealized gain (loss) on foreign currency hedges, net of tax                   $ 84    
Unrealized gain (loss) on interest rate hedges, net of tax                     $ 41  
Net actuarial pension gain (loss), net of tax $ 10                     $ 10
Balance at period end (in shares) at Mar. 28, 2026 0 0                    
Balance at end of period at Mar. 28, 2026 $ 12,181 $ 0 $ 860 $ 786,672 $ 787,345 $ (673) $ (718,406) $ (56,945)        
Balance at period end (in shares) at Mar. 28, 2026 86,120,743   86,120,743                  
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) (Parenthetical) - $ / shares
Mar. 28, 2026
Dec. 31, 2025
Mar. 29, 2025
Statement of Stockholders' Equity [Abstract]      
Preferred stock, par value (usd per share) $ 0.01 $ 0.01 $ 0.01
Common stock, par value (usd per share) $ 0.01 $ 0.01 $ 0.01
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
OPERATING ACTIVITIES    
Net loss $ (76,844) $ (190,138)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 29,370 27,295
Deferred income taxes 127 (3,123)
Net loss (gain) on sale of business, property, and equipment 76 (599)
Goodwill impairment 0 137,721
Adjustment to carrying value of assets 3,200 2,279
Amortization of deferred financing costs 563 535
Loss on extinguishment and refinancing of debt 0 237
Share-based compensation expense 3,682 3,228
Other items, net 422 (1,034)
Net change in operating assets and liabilities:    
Accounts receivable (71,101) (58,130)
Inventories (4,699) 21,295
Other assets 3,979 (3,151)
Accounts payable 32,946 6,753
Accrued expenses (12,078) (21,722)
Change in short-term and long-term tax liabilities (858) (4,940)
Net cash used in operating activities (91,215) (83,494)
INVESTING ACTIVITIES    
Purchases of property and equipment (25,096) (36,763)
Proceeds from sale of property and equipment 84 162
Purchases of intangible assets (982) (5,191)
Proceeds related to the court-ordered divestiture of Towanda 0 112,105
Cash received for notes receivable 5 7
Purchases of securities for deferred compensation plan (174) (273)
Net cash (used in) provided by investing activities (26,163) 70,047
FINANCING ACTIVITIES    
Change in long-term debt and payments of debt extinguishment costs 32,312 (6,064)
Common stock issued for exercise of options 2 2
Payments to tax authorities for employee share-based compensation (208) 0
Payments related to the sale of JW Australia 0 (540)
Net cash provided by (used in) financing activities 32,106 (6,602)
Effect of foreign currency exchange rates on cash (629) 2,174
Net decrease in cash and cash equivalents (85,901) (17,875)
Cash, cash equivalents and restricted cash, beginning 138,248 151,047
Cash, cash equivalents and restricted cash, ending $ 52,347 $ 133,172
v3.26.1
Description of Company and Summary of Significant Accounting Policies
 3 Months Ended
Mar. 28, 2026
Accounting Policies [Abstract]  
Description of Company and Summary of Significant Accounting Policies Description of Company and Summary of Significant Accounting Policies
Nature of Business – JELD-WEN Holding, Inc., along with its subsidiaries, is a vertically integrated global manufacturer and distributor of windows, doors, and other building products that derives substantially all its revenues from the sale of its door and window products. Unless otherwise specified or the context otherwise requires, all references in these notes to “JELD-WEN,” “we,” “us,” “our,” or the “Company” are to JELD-WEN Holding, Inc. and its subsidiaries.
Our continuing operations include facilities located in the U.S., Canada, and Europe. Our products are marketed primarily under the JELD-WEN brand name in the U.S. and Canada and under JELD-WEN and a variety of acquired brand names in Europe.
Our revenues are affected by the level of new housing starts, residential and non-residential building construction, and repair and remodeling activity in each of our markets. Our sales typically follow seasonal new construction and repair and remodeling industry patterns. The peak season for home construction and remodeling in many of our markets generally corresponds with the second and third calendar quarters, and therefore, sales volume is typically higher during those quarters. Our first and fourth quarter sales volumes are generally lower due to reduced repair and remodeling activity and reduced activity in the building and construction industry as a result of colder and more inclement weather in certain areas of our geographic end markets.
Basis of Presentation – The accompanying unaudited condensed consolidated financial statements as of March 28, 2026, and for the three months ended March 28, 2026, and March 29, 2025, have been prepared in accordance with GAAP for interim financial information and pursuant to the rules and regulations of the SEC. In the opinion of management, the unaudited condensed consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments, consisting only of normal recurring adjustments, necessary for the fair statement of the Company’s financial position for the periods presented. The results for the three months ended March 28, 2026, are not necessarily indicative of the results to be expected for the year ending December 31, 2026, or any other period. The accompanying unaudited condensed consolidated balance sheet as of December 31, 2025, was derived from audited financial statements included in our Annual Report on Form 10-K. The accompanying unaudited condensed consolidated financial statements do not include all the information and footnotes required by GAAP for annual financial statements. Accordingly, they should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025.
All U.S. dollar and other currency amounts, except share and per share amounts, are presented in thousands unless otherwise noted.
Fiscal Year – We operate on a fiscal calendar year, and each interim quarter is comprised of two 4-week periods and one 5-week period, with each week ending on a Saturday. Our fiscal year always begins on January 1 and ends on December 31. As a result, our first and fourth quarters may have more, or fewer days included than a traditional 91-day fiscal quarter.
Use of Estimates – The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets including goodwill (prior to impairment) and other intangible assets, employee benefit obligations, income tax uncertainties, contingent assets and liabilities, provisions for bad debt, inventory, warranty liabilities, legal claims, valuation of derivatives, environmental remediation, and claims relating to self-insurance. Actual results could differ due to the uncertainty inherent in these estimates.
Warranty Accrual – In Q4 2025, we corrected our warranty accrual calculation resulting in an additional $6.7 million of expense that should have been recognized in our prior interim periods in 2025. We have evaluated the impact on prior interim periods and concluded that the amounts were not material. Refer to Note 9 - Warranty Liability to our unaudited condensed consolidated financial statements included in this Form 10-Q for more information.
Recent Accounting Standards Not Yet Adopted – In November 2024, the FASB issued ASU 2024-03, Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses. ASU 2024-03 requires disclosure of disaggregated information about specific natural expense categories underlying certain income statement expense line items that are considered relevant. The FASB also issued ASU 2025-01, Expense Disaggregation Disclosures: Clarifying the Effective Date, which clarifies the adoption date of ASU 2024-03 as annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted, and the guidance should be applied either prospectively to financial statements issued for reporting dates after the effective date or retrospectively to any or all prior periods presented in the financial statements. We are currently evaluating the impact of this guidance on the Company’s disclosures.
In September 2025, the FASB issued ASU 2025-06, Targeted Improvements to the Accounting for Internal-Use Software. ASU 2025-06 amends certain aspects of the accounting for and disclosure of internal-use software costs under ASC 350-40. The guidance is effective for interim and annual periods beginning after December 15, 2027, with early adoption permitted, and can be applied prospectively, retrospectively, or with a modified transition approach. We are currently evaluating the impact of this guidance on the Company’s disclosures.
We have considered the applicability and impact of all ASUs. We have assessed the ASUs not listed above and determined that they were either not applicable or were not expected to have a material impact on our unaudited condensed consolidated financial statements.
v3.26.1
Divestiture
 3 Months Ended
Mar. 28, 2026
Discontinued Operations and Disposal Groups [Abstract]  
Divestiture Divestiture
Court-Ordered Divestiture of Towanda
On January 17, 2025, pursuant to an order issued by the United States District Court for the Eastern District of Virginia, Richmond Division, and the previously announced Asset Purchase Agreement dated October 11, 2024 and effective December 13, 2024, JWI completed the sale of its Towanda, PA operations to WG Towanda LLC, a wholly owned subsidiary of Woodgrain Inc. Towanda was previously included within the North America segment.
Since the Company will continue manufacturing door skins for its internal needs, the court-ordered divestiture decision did not represent a strategic shift thereby precluding the court-ordered divestiture as qualifying as a discontinued operation.
The selling price of Towanda was $115.0 million, subject to certain adjustments and closing conditions, paid in cash during the first quarter of 2025. We recorded a $0.7 million pre-tax gain on the sale of Towanda, within SG&A in our unaudited condensed consolidated statement of operations during the first quarter of 2025. The gain is driven by a post-close net working capital adjustment. Towanda had a net carrying value of $110.8 million, which included property and equipment, net of $65.4 million, inventories of $16.7 million, trade receivables of $8.8 million, operating lease assets, net of $2.2 million, intangible assets, net of $1.5 million, and goodwill of $33.6 million. The goodwill is not deductible for tax purposes. The assets were partially offset by accounts payable of $9.2 million and other liabilities which were individually immaterial. We recorded $8.5 million in tax expense related to the gain from the sale within income tax expense in the accompanying unaudited condensed consolidated statement of operations during the first quarter of 2025, of which $7.8 million was offset with a change in our tax valuation allowance in the third quarter of 2025.
v3.26.1
Accounts Receivable, Net
 3 Months Ended
Mar. 28, 2026
Receivables [Abstract]  
Accounts Receivable, Net Accounts Receivable, Net
We sell our manufactured products to many customers, primarily in the residential housing construction and remodel sectors, broadly dispersed across many domestic and foreign geographic regions. We assess the credit risk relating to our accounts receivable based on quantitative and qualitative factors, including historical credit collections within each region where we have operations. We perform ongoing credit evaluations of our customers to minimize credit risk. We do not usually require collateral for accounts receivable, but do require advance payment, guarantees, a security interest in the products sold to a customer, and/or letters of credit in certain situations. Customer accounts receivable converted to notes receivable are collateralized by inventory or other collateral.
At March 28, 2026 and December 31, 2025, we had an allowance for credit losses of $11.7 million and $11.1 million, respectively.
v3.26.1
Inventories
 3 Months Ended
Mar. 28, 2026
Inventory Disclosure [Abstract]  
Inventories Inventories
Inventories are stated at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor, and manufacturing overhead costs.
(amounts in thousands)March 28, 2026December 31, 2025
Raw materials$360,836 $365,418 
Work in process25,680 21,988 
Finished goods89,102 85,642 
Inventory valuation reserves(29,427)(28,946)
Total inventories$446,191 $444,102 
v3.26.1
Property and Equipment, Net
 3 Months Ended
Mar. 28, 2026
Property, Plant and Equipment [Abstract]  
Property and Equipment, Net Property and Equipment, Net
(amounts in thousands)March 28, 2026December 31, 2025
Property and equipment$2,102,986 $2,102,835 
Accumulated depreciation(1,378,699)(1,374,390)
Total property and equipment, net$724,287 $728,445 
During the three months ended March 28, 2026, we recorded an impairment charge of $3.1 million within SG&A and accelerated depreciation of $1.2 million within cost of sales in the accompanying unaudited condensed consolidated statement of operations, each related to property and equipment identified through our North America equipment capacity optimization review.
The effect on our carrying value of property and equipment, net due to currency translations for foreign property and equipment, net, was a decrease of $4.3 million as of March 28, 2026, compared to December 31, 2025.
Depreciation expense was recorded as follows:
Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Cost of sales$21,586 $19,172 
Selling, general, and administrative1,266 1,178 
Total depreciation expense$22,852 $20,350 
v3.26.1
Goodwill
 3 Months Ended
Mar. 28, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill Goodwill
As previously disclosed, the Company recognized non‑cash goodwill impairment charges of $137.7 million and $196.9 million in the three months ended March 29, 2025 and September 27, 2025, respectively. As a result, goodwill was fully impaired at December 31, 2025. Refer to our 2025 Form 10‑K for the annual rollforward and additional details.
Goodwill was tested for impairment on an annual basis during the fourth quarter and between annual tests if indicators of potential impairment existed. The goodwill impairment tests were based on determining the fair value of the specified reporting units using management judgments and assumptions under two valuation approaches: discounted cash flows under the income approach (classified in Level 3 of the fair value hierarchy) and comparable company market valuation under the market approach (classified in Level 2 of the fair value hierarchy).
v3.26.1
Intangible Assets, Net
 3 Months Ended
Mar. 28, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets, Net Intangible Assets, Net
The cost and accumulated amortization values of our intangible assets were as follows:
March 28, 2026
(amounts in thousands)CostAccumulated
Amortization		Net
Book Value
Customer relationships and agreements$126,427 $(107,018)$19,409 
Software88,518 (41,017)47,501 
Trademarks and trade names32,641 (14,829)17,812 
Patents, licenses and rights15,412 (7,042)8,370 
Total amortizable intangibles$262,998 $(169,906)$93,092 
December 31, 2025
(amounts in thousands)CostAccumulated
Amortization		Net
Book Value
Customer relationships and agreements$127,659 $(106,339)$21,320 
Software89,225 (40,708)48,517 
Trademarks and trade names32,804 (14,510)18,294 
Patents, licenses and rights14,931 (6,732)8,199 
Total amortizable intangibles$264,619 $(168,289)$96,330 
Amortization expense was recorded as follows:
Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Amortization expense$5,051 $5,493 
v3.26.1
Accrued Expenses and Other Current Liabilities
 3 Months Ended
Mar. 28, 2026
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:
(amounts in thousands)March 28, 2026December 31, 2025
Accrued sales and advertising rebates$59,740 $72,840 
Current portion of operating lease liability36,898 33,761 
Non-income related taxes22,115 18,786 
Current portion of warranty liability (Note 9)
20,554 21,321 
Accrued expenses18,329 17,958 
Accrued freight17,129 14,779 
Current portion of accrued claim costs relating to self-insurance programs14,446 15,166 
Accrued interest payable9,633 9,224 
Legal claims provision (Note 20)
9,232 3,156 
Deferred revenue and customer deposits3,988 4,946 
Current portion of restructuring accrual (Note 16)
3,739 9,003 
Accrued income taxes payable1,661 1,583 
Current portion of derivative liability (Note 18)
783 624 
Total accrued expenses and other current liabilities$218,247 $223,147 
v3.26.1
Warranty Liability
 3 Months Ended
Mar. 28, 2026
Product Warranties Disclosures [Abstract]  
Warranty Liability Warranty Liability
Warranty terms range from one year to lifetime on certain window and door components. Warranties are normally limited to servicing or replacing defective components for the original customer. Product defects arising within six months of sale are classified as manufacturing defects and are not included in the current period expense below. Some warranties are transferable to subsequent owners and are either limited to 10 years from the date of manufacture or require pro rata payments from the customer. Estimated warranty costs based on historical experience are recorded as a provision at the time of sale. The provision is adjusted periodically to reflect actual experience.
An analysis of our warranty liability is as follows:
(amounts in thousands)March 28, 2026March 29, 2025
Balance as of January 1,$40,676 $47,289 
Current period charges4,932 2,943 
Payments(5,714)(5,820)
Currency translation(127)295 
Balance at period end39,766 44,707 
Current portion(20,554)(18,759)
Long-term portion$19,212 $25,948 
The most significant component of our warranty liability was in the North America segment. As of March 28, 2026, the warranty liability in the North America segment totaled $35.6 million, after discounting future estimated cash flows at rates between 3.55% and 4.19%. Without discounting, the liability would have increased by approximately $2.8 million.
v3.26.1
Long-Term Debt
 3 Months Ended
Mar. 28, 2026
Debt Disclosure [Abstract]  
Long-Term Debt Long-Term Debt
Our long-term debt, net of unamortized debt issuance costs and original issue discounts, consisted of the following:
(amounts in thousands)March 28, 2026 Interest RatesMarch 28, 2026December 31, 2025
Revolving Credit Facility
5.03%(1)
$40,000 $— 
Senior Notes due December 2027
4.88%
400,000 400,000 
Term Loan Facility due July 2028
5.79%(1)
375,525 375,525 
Senior Notes due September 2032
7.00%
350,000 350,000 
Finance leases and other financing arrangements
1.00% - 8.28%(1)
49,661 54,458 
Total debt$1,215,186 $1,179,983 
Unamortized debt issuance costs and original issue discounts(6,224)(6,679)
Current maturities of long-term debt(19,526)(23,690)
Long-term debt$1,189,436 $1,149,614 
(1)Term Loan Facility due July 2028, Revolving Credit Facility, and certain finance leases and other financing arrangements are subject to variable interest rates.
Summaries of our significant changes to outstanding debt agreements as of March 28, 2026, are as follows:
Our total indebtedness as of March 28, 2026, was $1.22 billion of which $19.5 million in short-term debt obligations is due and payable within the next 12 months. We have $400 million of Senior Notes due in December 2027 for which it is unlikely that our cash flows from operations will be sufficient to fully repay. To service our indebtedness, we may be required to undertake various actions including, but not limited to, refinancing all or a portion of our existing long-term debt, pursuing strategic reviews of our assets and businesses, entering into sale-leaseback transactions for selected properties, adjusting our planned level of capital and other expenditures, or other strategies. In addition, in accordance with our credit agreements, dispositions of assets or businesses may require us to use all or a portion of the proceeds of such sales to pay down certain portions of our debt.
Senior Notes
In December 2017, we issued $400 million of Senior Notes bearing interest at 4.88% and maturing in December 2027 in a private placement for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act.
In August 2024, we issued $350.0 million of Senior Notes bearing interest at 7.00% and maturing September 2032 in a private placement for resale to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The proceeds were net of fees and expenses associated with debt issuance including an underwriting fee of 1.25%. We incurred debt issuance costs of $5.5 million which will be amortized to interest expense over the life of the notes using the effective interest method. Interest is payable semiannually, in arrears, each March and September.
In September 2024, we utilized a portion of the proceeds from the issuance of our 7.00% Senior Notes described above to redeem the remaining $200.0 million of our 4.63% Senior Notes. The Company recognized a pre-tax loss of $0.5 million on the redemption in the third quarter of 2024, consisting entirely of accelerated amortization of debt issuance costs.
Term Loan Facility
U.S. Facility – Initially executed in October 2014, we amended the Term Loan Facility in July 2021 to, among other things, extend the maturity date from December 2024 to July 2028 and provide additional covenant flexibility.
In January 2024, we amended the Term Loan Facility to lower the applicable margin for replacement term loans, remove certain provisions no longer relevant to the parties, and make certain other technical amendments and related conforming changes. Pursuant to the amendment, replacement term loans bear interest at SOFR plus a margin of 1.75% to 2.00% depending on JWI’s corporate credit ratings, compared to a margin of 2.00% to 2.25% under the previous amendment. All other material terms and conditions of the Term Loan Agreement were unchanged. As a result of this amendment, we recognized debt extinguishment and refinancing costs of $1.4 million, which included $0.8 million of unamortized debt issuance costs and original discount fees.
In February 2024, we entered into interest rate collar agreements with a cap rate of 4.50% paid against one-month USD-SOFR CME Term floored at 3.982% and 3.895% with outstanding notional amounts aggregating to $100.0 million corresponding to that amount of the debt outstanding under our Term Loan Facility. The interest rate collar agreements were designated as cash flow hedges of a portion of the interest obligations on our Term Loan Facility borrowings and matured in February 2026. Refer to Note 18 - Derivative Financial Instruments to our unaudited condensed consolidated financial statements included in this Form 10-Q for more information on our derivative assets and liabilities.
In August 2024, we utilized a portion of the proceeds received from our issuance of $350.0 million of Senior Notes to repay $150.0 million of the outstanding balance of our Term Loan Facility. As of March 28, 2026, the outstanding principal balance, net of original issue discount, was $375.3 million.
Revolving Credit Facility
ABL Facility – Initially executed in 2014, extensions of credit under our ABL Facility are limited by a borrowing base calculated based on specified percentages of the value of eligible accounts receivable and inventory, subject to certain reserves and other adjustments. We pay a fee of 0.25% on the unused portion of the commitments. If there are outstanding borrowings against the ABL Facility, which results in the Company’s Global Excess Availability falling below the Level 1 Availability Trigger Amount, we would be required to comply with a minimum Fixed Charge Coverage Ratio as described in the ABL Facility credit agreement. The ABL Facility has various non-financial covenants, including restrictions on liens, indebtedness, dividends, customary representations and warranties, and customary events of defaults and remedies.
In March 2025, we amended the ABL Facility to extend the maturity date from July 2026 to March 2028, replace the CDOR as the applicable rate with respect to loans denominated in Canadian Dollars with the CORRA, and make certain other technical amendments and related conforming changes. All other material terms and conditions of the ABL Facility credit agreement were unchanged, including the aggregate commitment, which remained at $500.0 million. As a result of this amendment, the Company recognized a pre-tax loss of $0.2 million in the first quarter of 2025, consisting of unamortized issuance costs.
As of March 28, 2026, we had $40.0 million outstanding net borrowings under the ABL Facility, $22.0 million in letters of credit, and $259.5 million available under the ABL Facility.
Finance leases and other financing arrangements
In addition to finance leases, we include loans secured by equipment in this category. As of March 28, 2026, we had $49.7 million outstanding in this category, with maturities ranging from 2026 to 2032.
As of March 28, 2026, we were in compliance with the terms of all our Credit Facilities and the indentures governing the Senior Notes.
v3.26.1
Income Taxes
 3 Months Ended
Mar. 28, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The effective income tax rate was (4.6)% and (0.3)% for the three months ended March 28, 2026 and March 29, 2025, respectively. The Company recorded income tax expense of $3.4 million and $0.6 million in the three months ended March 28, 2026 and March 29, 2025, respectively. We applied our estimated annual effective tax rate to year-to-date income for includable entities during the respective periods. Entities that are currently generating losses and for which there is a full valuation allowance are excluded from the worldwide effective tax rate calculation and are calculated separately.
Under ASC 740-10, we provide for UTPs and the related interest expense by adjusting unrecognized tax benefits and accrued interest accordingly. We recognize potential interest and penalties related to UTPs in income tax expense. As of March 28, 2026 and December 31, 2025, we had a liability for unrecognized tax benefits without regard to accrued interest of $46.7 million and $47.5 million, respectively.
We continually evaluate our global cash needs and have historically maintained a partial indefinite reinvestment assertion on our post-2017 undistributed foreign earnings.
v3.26.1
Segment Information
 3 Months Ended
Mar. 28, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
We report our segment information in the same way management internally organizes the business to assess performance and make decisions regarding the allocation of resources in accordance with ASC 280-10 - Segment Reporting. Management, inclusive of the CODM, reviews net revenues and Adjusted EBITDA to evaluate segment performance and allocate resources. We define Adjusted EBITDA as income (loss), net of tax, adjusted for the following items: income tax expense (benefit); depreciation and amortization; interest expense (income), net; and certain special items consisting of non-recurring net legal and professional expenses and settlements; goodwill impairment; restructuring and asset-related charges, net; M&A related costs, net; net gain on sale of business, property and equipment; loss on extinguishment and refinancing of debt; share-based compensation expense; and other special items. We use Adjusted EBITDA because we believe this measure assists investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. For each of our segments, our CODM uses Adjusted EBITDA to measure operational performance by comparing historical, actual and forecasted amounts on a regular basis, and to allocate resources in the annual budget and forecasting process. Adjusted EBITDA is also a significant performance measure in our annual incentive compensation.
We have two reportable segments, organized and managed principally in geographic regions: North America and Europe. We report all other business activities in Corporate and unallocated costs. The Company’s two reportable segments are defined as follows:
North America – Within our North America segment, the Company supplies windows and doors for residential and commercial markets, serving both new construction and repair & remodel projects. These products reach builders, repair and replacement contractors, architects, and homebuilders through direct and indirect channels, including dealer and distribution networks.
Europe – Within our Europe segment, the Company manufactures and supplies to retailers, merchants, housebuilders and construction companies’ interior doors, doorsets and door kits, in wood and steel, with both standard and high-performance features.
Factors considered in determining the two reportable segments include the nature of business activities, the management structure accountable directly to the CODM, the discrete financial information regularly provided to the CODM, and information presented to the Board of Directors and investors. The CODM is the CEO. No operating segments have been aggregated for our presentation of reportable segments.
Three Months Ended March 28, 2026
(amounts in thousands)North
America 		EuropeTotal
Revenues from external customers$452,713 $269,412 $722,125 
Intersegment net revenues— — — 
Total segment net revenues$452,713 $269,412 $722,125 
Reconciliation of Revenue
Elimination of intersegment net revenues— 
Total consolidated net revenues$722,125 
Less:
Adjusted cost of sales$408,712 $217,256 $625,968 
Adjusted selling, general and administrative58,964 52,196 111,160 
Other segment items(1)
(18,582)(7,116)(25,698)
Adjusted EBITDA$3,619 $7,076 $10,695 
Total Reportable Segment Adjusted EBITDA$10,695 
Less:
Depreciation and amortization29,370 
Interest expense, net17,203 
Corporate and unallocated costs4,554 
Special items:
Net legal and professional expenses and settlements12,767 
Restructuring and asset-related charges, net1,979 
M&A related costs, net7,599 
Share-based compensation expense3,682 
Other special items(2)
7,009 
Loss, before tax$(73,468)
(1)Other segment items included depreciation and amortization, which are included as a component of the significant expense categories regularly provided to the CODM above but are not included in the measure of segment profit, as well as other items, which are excluded from the categories regularly provided to the CODM, which primarily included:
North America - Foreign currency losses.
Europe - Foreign currency losses and pension expense.
(2)Other special items not core to ongoing business activity included an impairment of $3.1 million in our North America reporting unit as a result of reviews performed in connection with our North America equipment capacity optimization.
Three Months Ended March 28, 2026
(amounts in thousands)North
America 		EuropeCorporate
and
Unallocated
Costs		Total
Consolidated
Depreciation and amortization
$18,829 $8,384 $2,157 $29,370 
Capital expenditures15,317 9,824 937 26,078 
Segment assets
1,263,792 683,981 129,495 2,077,268 
Three Months Ended March 29, 2025
(amounts in thousands)North
America 		EuropeTotal
Revenues from external customers$530,561 $245,445 $776,006 
Intersegment net revenues33 489 522 
Total segment net revenues$530,594 $245,934 $776,528 
Reconciliation of Revenue
Elimination of intersegment net revenues(522)
Total consolidated net revenues$776,006 
Less:
Adjusted cost of sales$465,648 $197,854 $663,502 
Adjusted selling, general and administrative69,499 44,261 113,760 
Other segment items(1)
(20,110)(7,327)(27,437)
Adjusted EBITDA$15,524 $10,657 $26,181 
Total Reportable Segment Adjusted EBITDA$26,181 
Less:
Depreciation and amortization27,295 
Interest expense, net14,918 
Corporate and unallocated costs4,312 
Special items:
Net legal and professional expenses and settlements11,882 
Goodwill impairment137,721 
Restructuring and asset-related charges, net14,546 
M&A related costs, net(613)
Net gain on sale of business, property, and equipment(653)
Loss on extinguishment and refinancing of debt237 
Share-based compensation expense3,228 
Other special items2,828 
Loss, before tax$(189,520)
(1)Other segment items included depreciation and amortization, which are included as a component of the significant expense categories regularly provided to the CODM above but are not included in the measure of segment profit, as well as other items, which are excluded from the categories regularly provided to the CODM, which primarily included:
North America - Refund of deposits for antidumping and countervailing duties on wood mouldings and millwork products purchased from China from 2022 to 2023.
Europe - Pension expense and foreign currency losses.
Three Months Ended March 29, 2025
(amounts in thousands)North
America 		EuropeCorporate
and
Unallocated
Costs		Total
Consolidated
Depreciation and amortization
$17,325 $7,565 $2,405 $27,295 
Capital expenditures27,736 10,290 3,928 41,954 
Segment assets
1,349,336 774,988 294,591 2,418,915 
v3.26.1
Capital Stock
 3 Months Ended
Mar. 28, 2026
Equity [Abstract]  
Capital Stock Capital Stock
Preferred Stock – Our Board of Directors is authorized to issue Preferred Stock from time to time in one or more series and with such rights, privileges, and preferences as the Board of Directors shall from time to time determine. We have not issued any shares of Preferred Stock.
Common Stock – Common Stock includes the basis of outstanding shares plus amounts recorded as additional paid-in capital. Shares outstanding exclude the shares issued to the Employee Benefit Trust that are considered similar to treasury shares and total 193,941 shares at both March 28, 2026 and December 31, 2025, with a total original issuance value of $12.4 million.
We record share repurchases on their trade date and reduce shareholders’ equity and increase accounts payable. Repurchased shares are retired, and the excess of the repurchase price over the par value of the shares is charged to retained earnings.
On July 28, 2022, the Board of Directors reduced our previous repurchase authorization of $400.0 million to a total aggregate value of $200.0 million with no expiration date. As of March 28, 2026, $175.7 million remained under the repurchase program.
During the three months ended March 28, 2026 and March 29, 2025, we did not repurchase shares of our Common Stock.
v3.26.1
Loss Per Share
 3 Months Ended
Mar. 28, 2026
Earnings Per Share [Abstract]  
Loss Per Share Loss Per Share
The basic and diluted loss per share calculations were determined based on the following share data:
Three Months Ended
March 28, 2026March 29, 2025
Weighted average outstanding shares of Common Stock basic85,803,503 84,917,294 
Restricted stock units, performance share units and options to purchase Common Stock— — 
Weighted average outstanding shares of Common Stock diluted85,803,503 84,917,294 
For the three months ended March 28, 2026 and March 29, 2025, we had net losses from operations. As a result, no potentially dilutive securities were included in the denominator for computing diluted loss per share as their inclusion would have been antidilutive.
The following table provides the securities that could potentially dilute basic earnings per share in the future but were not included in the computation of diluted income per share as their inclusion would be anti-dilutive:
Three Months Ended
March 28, 2026March 29, 2025
Common Stock options1,289,560 1,558,883 
Restricted stock units2,295,706 1,205,152 
Performance share units573,306 64,781 
v3.26.1
Share-Based Compensation
 3 Months Ended
Mar. 28, 2026
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
The activity under our incentive plans for the periods presented is reflected in the following tables:
Three Months Ended
March 28, 2026March 29, 2025
SharesWeighted Average Exercise Price Per ShareSharesWeighted Average Exercise Price Per Share
Options granted— $— 536,432 $9.05 
Options cancelled5,568 $33.34 41,989 $22.28 
SharesWeighted Average Grant Date Fair ValueSharesWeighted Average Grant Date Fair Value
RSUs granted1,150,708 $2.72 1,386,301 $9.02 
PSUs granted— $— 620,673 $9.47 
PSUs performance adjustment(181,281)$— — $— 
Share-based compensation expense was $3.7 million and $3.2 million for the three months ended March 28, 2026, and March 29, 2025, respectively. As of March 28, 2026, we had $12.7 million of total unrecognized share-based compensation expense related to non-vested share-based compensation arrangements. This cost is expected to be recognized over the remaining weighted-average vesting period of 1.5 years.
On February 23, 2026, the Company modified certain underwater options and a subset of 2024 PSUs to require cash settlement. For the modified underwater options, the modification resulted in a classification change from equity to liability. In accordance with ASC 718, the Company records a share‑based compensation liability for the modified options measured at fair value and remeasured at each reporting date until settlement, with changes recognized in share‑based compensation expense included within SG&A in the accompanying unaudited condensed consolidated statement of operations. The Company measured the share‑based compensation liability as of quarter‑end using a Black‑Scholes valuation. For the cash‑settled subset of the 2024 PSUs, the Company currently assesses the performance conditions as not probable. Accordingly, no share‑based compensation expense was recognized at the modification date or through March 28, 2026. The Company will reassess the probability of achievement each reporting period and, if performance conditions are probable, will recognize share‑based compensation expense and a related liability, with subsequent remeasurement through earnings until settlement.
v3.26.1
Restructuring and Asset-Related Charges, Net
 3 Months Ended
Mar. 28, 2026
Restructuring and Related Activities [Abstract]  
Restructuring and Asset-Related Charges, Net Restructuring and Asset-Related Charges, Net
We engage in restructuring activities focused on improving productivity and operating margins. Restructuring costs primarily relate to costs associated with workforce reductions, plant consolidations and closures, and changes to the management structure to align with our operations. Other restructuring associated costs, net primarily consist of equipment relocation and facility restoration costs. Asset-related charges, net consist of accelerated depreciation and amortization of assets due to changes in asset useful lives.
(amounts in thousands)North
America 		EuropeCorporate
and
Unallocated
Costs		Total
Consolidated
Three Months Ended March 28, 2026
Restructuring severance and employee-related charges, net$456 $81 $33 $570 
Other restructuring associated costs, net336 977 — 1,313 
Asset-related charges, net— 96 — 96 
Other restructuring associated costs and asset-related charges, net336 1,073 — 1,409 
Total restructuring and asset-related charges, net$792 $1,154 $33 $1,979 
Three Months Ended March 29, 2025
Restructuring severance and employee-related charges, net(1)
$10,019 $1,850 $736 $12,605 
Other restructuring associated costs, net644 1,131 — 1,775 
Asset-related charges, net— 166 — 166 
Other restructuring associated costs and asset-related charges, net644 1,297 — 1,941 
Total restructuring and asset-related charges, net$10,663 $3,147 $736 $14,546 
(1)In the first quarter of fiscal 2025, the Company implemented a reduction in force, which was substantially complete as of March 29, 2025. The charges incurred in the three months ended March 29, 2025, were included in restructuring and asset-related charges, net in the accompanying unaudited condensed consolidated statement of operations and include $0.7 million related to Corporate.
The following is a summary of the restructuring accruals recorded, and charges incurred:
(amounts in thousands)March 28, 2026December 31, 2025
Balance as of January 1,$9,003 $7,605 
Current period charges, net1,884 41,362 
Payments(7,096)(40,508)
Currency translation(52)544 
Balance at period end$3,739 $9,003 
Restructuring accruals are expected to be paid within the next twelve months and are included within accrued expenses and other current liabilities in the accompanying unaudited condensed consolidated balance sheets.
North America
From 2023 to 2025, we announced plans to transform our North American operations by changing the operating structure, eliminating certain roles, and rationalizing our manufacturing footprint. Except for our Chiloquin, Oregon facility, we have substantially completed the closure of all previously disclosed facilities in North America, and we expect to substantially complete the closure of the Chiloquin facility by the end of 2026.
During the first quarter of 2026, we announced additional plans after identifying further opportunities to optimize our North American structure. As of March 28, 2026, the remaining restructuring accrual for our North America initiatives is $1.2 million, and the remaining cash outlay is expected to be $7.5 million.
Costs and cash outlays associated with the plans are as follows:
Total Estimated CostsCumulative Costs to-dateCosts in the Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Restructuring severance and employee-related charges, net(1)
$36,600 $35,009 $456 $10,019 
Other restructuring associated costs, net(1)
17,700 12,820 336 644 
Product-related cash charges(2)
6,700 6,719 — 134 
Total cash charges$61,000 $54,548 $792 $10,797 
Asset-related charges, net(1)
24,900 23,974 — — 
Inventory and other product-related non-cash charges, net(3)
9,300 9,061 (82)1,121 
Total non-cash charges$34,200 $33,035 $(82)$1,121 
Total costs$95,200 $87,583 $710 $11,918 
Total cash outlays(4)
$67,600 $60,092 $3,422 $5,556 
(1)The charges incurred in the three months ended March 28, 2026 and March 29, 2025, were included in restructuring and asset-related charges, net in the accompanying unaudited condensed consolidated statements of operations.
(2)The product-related cash charges incurred in the three months ended March 29, 2025, were detrimental to net sales in the accompanying unaudited condensed consolidated statement of operations.
(3)The inventory and other product-related non-cash charges, net in the three months ended March 28, 2026 and March 29, 2025, were included in cost of sales in the accompanying unaudited condensed consolidated statement of operations.
(4)Total cash outlays include $5.5 million of cash payments related to debt repayment for financed equipment, and a $0.9 million lease termination fee.
Europe
From 2023 to 2025, we announced plans to transform our European operations by changing the operating structure, eliminating certain roles, and rationalizing our manufacturing footprint. Except for our Sheffield, England facility, we have substantially completed the closure of all previously disclosed facilities in Europe, and we expect to substantially complete the closure of the Sheffield facility by the end of 2026.
As of March 28, 2026, the remaining restructuring accrual for our Europe initiatives is $2.3 million, and the remaining cash outlay is expected to be $5.5 million.
Costs and cash outlays associated with the plans are as follows:
Total Estimated CostsCumulative Costs to-dateCosts in the Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Restructuring severance and employee-related charges, net(1)
$32,000 $30,969 $81 $1,850 
Other restructuring associated costs, net(1)
17,000 14,706 977 1,131 
Total cash charges$49,000 $45,675 $1,058 $2,981 
Asset-related charges, net(1)
2,700 1,880 96 166 
Total costs$51,700 $47,555 $1,154 $3,147 
Total cash outlays$49,000 $43,570 $2,843 $4,600 
(1)The charges incurred in the three months ended March 28, 2026 and March 29, 2025, were included in restructuring and asset-related charges, net in the accompanying unaudited condensed consolidated statements of operations.
v3.26.1
Other Expense (Income)
 3 Months Ended
Mar. 28, 2026
Other Income and Expenses [Abstract]  
Other Expense (Income) Other Expense (Income)
The table below summarizes the amounts included in other expense (income) in the accompanying unaudited condensed consolidated statements of operations:
Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Foreign currency losses (gains), net$1,075 $(209)
Pension expense494 867 
Governmental assistance(5)(3)
Cash received on real estate investment(1)
— (7,567)
Income from refund of deposits for China antidumping and countervailing duties, net(2)
— (2,859)
Gains on commodity derivatives— (361)
Other items, net(521)(454)
Total other expense (income)
$1,043 $(10,586)
(1)Cash received on real estate investment represents recovery of an investment in real estate development in Mexico.
(2)Represents income from the refund of deposits for antidumping and countervailing duties on wood mouldings and millwork products purchased from China from 2020 to 2023.
v3.26.1
Derivative Financial Instruments
 3 Months Ended
Mar. 28, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
Foreign currency derivatives not designated as hedges – As a multinational corporation, we are exposed to foreign currency fluctuations. When borrowings, sales, purchases, or other transactions are denominated in a currency other than the operating unit’s functional currency, we are exposed to foreign currency risk. In most of the countries in which we operate, this exposure to foreign currency movements is limited because operating revenues and expenses of our business units are substantially denominated in the local currency. To mitigate this exposure, we may enter into foreign currency derivative contracts. As of March 28, 2026, we had foreign currency derivative contracts with a total notional amount of $309.2 million to manage the effects of exchange fluctuations on certain intercompany transactions and intercompany loans and interest denominated in foreign currencies. We do not use derivative financial instruments for trading or speculative purposes. We record mark-to-market changes in the values of these derivatives as well as settlements of derivative contracts in other expense (income) on our unaudited condensed consolidated statements of operations.
Foreign currency derivatives designated as cash flow hedges – At the end of 2024, we implemented a hedging program to manage variability in cash flows associated with the amounts payable on raw material purchases denominated in foreign currencies. Gains and losses on foreign currency derivative contracts that qualify as cash flow hedges are recorded in AOCL, to the extent the hedges are effective, and are reclassified into cost of sales on our unaudited condensed consolidated statements of operations when the underlying transactions affect net earnings. This cash flow hedging program continued during 2025 and concluded with no outstanding cash flow hedge derivative contracts as of March 28, 2026 and December 31, 2025, respectively.
No portion of these derivative contracts were deemed ineffective during the three months ended March 29, 2025. In other comprehensive (loss) income, we recorded a pre-tax mark-to-market loss of $1.6 million during the three months ended March 29, 2025.
Commodity derivatives not designated as hedges – As part of our operations, we are exposed to price changes in certain commodities used in the production of some of our finished products. To limit the effects of fluctuations in the future market price paid, we may enter into non-designated derivative contracts to manage the cost of anticipated purchases. We do not use derivative financial instruments for trading or speculative purposes. We record mark-to-market changes in the values of these derivatives as well as settlements of derivative contracts in other expense (income) on our unaudited condensed consolidated statements of operations. We had no open commodity forward swap contracts as of March 28, 2026.
Commodity derivatives designated as cash flow hedges – As part of our operations, we are exposed to price changes in certain commodities used in the production of some of our finished products. To limit the effects of fluctuations in the future market price paid and related volatility in cash flows, we may enter into commodity forward swap contracts that are designated as cash flow hedges. Accordingly, the related gains or losses are reported in AOCL and reclassified into cost of sales, in the periods in which the hedged transactions affect earnings. We had no open commodity forward contracts as of March 28, 2026. We recorded pre-tax mark-to-market gains of $0.2 million for the three months ended March 29, 2025.
As of March 28, 2026, no unrealized gains or losses are expected to be reclassified to earnings over the next 12 months.
Interest rate derivatives – We are exposed to interest rate risk in connection with our variable rate long-term debt. In February 2024, we entered into interest rate collar agreements with a cap rate of 4.50% paid against one-month USD-SOFR CME Term floored at 3.982% and 3.895% with outstanding notional amounts aggregating to $100.0 million corresponding to that amount of the debt outstanding under our Term Loan Facility. The interest rate collar agreements were designated as cash flow hedges of a portion of the interest obligations on our Term Loan Facility borrowings and matured in February 2026.
No portion of these interest rate contracts were deemed ineffective during the three months ended March 28, 2026 and March 29, 2025. In other comprehensive (loss) income, we recorded a nominal pre-tax mark-to-market loss during the three months ended March 28, 2026. We recorded a pre-tax mark-to-market loss of $0.2 million during the three months ended March 29, 2025.
As of March 28, 2026, no unrealized gains or losses are expected to be reclassified to earnings over the next twelve months.
The fair values of derivative instruments held are as follows:
Derivative Assets
(amounts in thousands)Balance Sheet LocationMarch 28, 2026December 31, 2025
Foreign currency forward contractsOther current assets$442 $539 
Derivative Liabilities
(amounts in thousands)Balance Sheet LocationMarch 28, 2026December 31, 2025
Derivatives designated as hedging instruments:
Interest rate contractsAccrued expenses and other current liabilities— 41 
Derivatives not designated as hedging instruments:
Foreign currency forward contractsAccrued expenses and other current liabilities$783 $583 
The effect of derivative instruments in the unaudited condensed consolidated statements of operations is as follows:
Location of (Loss) Gain Recognized in Condensed Consolidated Statements of Operations
Amount of (Loss) Gain Recognized in Earnings on Derivatives
Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Derivatives designated as hedging instruments:
Foreign currency forward contractsCost of sales$(106)$47 
Commodity contractsCost of sales— 35 
Interest rate contractsInterest expense, net(39)— 
Derivatives not designated as hedging instruments:
Foreign currency forward contractsOther expense (income)(1,120)(752)
Commodity contractsOther expense (income)— 361 
Total$(1,265)$(309)
v3.26.1
Fair Value of Financial Instruments
 3 Months Ended
Mar. 28, 2026
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
We record financial assets and liabilities at fair value based on FASB guidance related to fair value measurements. The guidance requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Three levels of inputs may be used to measure fair value:
Level 1 – Quoted prices in active markets for identical assets or liabilities.
Level 2 – Quoted market-based inputs or unobservable inputs that are corroborated by market data.
Level 3 – Unobservable inputs that are not corroborated by market data.
The recorded carrying amounts and fair values of these instruments were as follows:
March 28, 2026
(amounts in thousands)Carrying AmountTotal
Fair Value		Level 1Level 2Level 3
Assets measured at NAV(1)
Assets:
Cash equivalents$18,268 $18,268 $18,268 $— $— $— 
Derivative assets, recorded in other current assets442 442 — 442 — — 
Deferred compensation plan assets, recorded in other assets5,163 5,163 — 5,163 — — 
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt$1,215,186 $843,673 $— $843,673 $— $— 
Derivative liabilities, recorded in accrued expenses and other current liabilities783 783 — 783 — — 
Deferred compensation plan liabilities, recorded in deferred credits and other liabilities5,170 5,170 — 5,170 — — 
December 31, 2025
(amounts in thousands)Carrying AmountTotal
Fair Value		Level 1Level 2Level 3
Assets measured at NAV(1)
Assets:
Cash equivalents$65,386 $65,386 $65,386 $— $— $— 
Derivative assets, recorded in other current assets539 539 — 539 — — 
Deferred compensation plan assets, recorded in other assets5,773 5,773 — 5,773 — — 
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt$1,179,983 $974,915 $— $974,915 $— $— 
Derivative liabilities, recorded in accrued expenses and other current liabilities624 624 — 624 — — 
Deferred compensation plan liabilities, recorded in deferred credits and other liabilities5,778 5,778 — 5,778 — — 
Derivative assets and liabilities reported in level 2 primarily include: (1) as of March 28, 2026, foreign currency derivative contracts; (2) as of December 31, 2025, foreign currency derivative contracts and interest rate collar agreements. Refer to Note 18 - Derivative Financial Instruments to our unaudited condensed consolidated financial statements included in this Form 10-Q for more information.
Deferred compensation plan assets reported in level 2 consist of mutual funds and corporate-owned life insurance.
There are no material non-financial assets or liabilities as of March 28, 2026 or December 31, 2025.
v3.26.1
Commitments and Contingencies
 3 Months Ended
Mar. 28, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Litigation – We are involved in various legal proceedings, claims, and government audits arising in the ordinary course of business. We record our best estimate of a loss when the loss is considered probable, and the amount of such loss can be reasonably estimated. When a loss is probable and there is a range of estimated loss with no best estimate within the range, we record the minimum estimated liability related to the lawsuit or claim. As additional information becomes available, we reassess the potential liability and revise our accruals, if necessary. Because of uncertainties related to the resolution of lawsuits and claims, the ultimate outcome may differ materially from our estimates.
Other than the matters described below, there were no proceedings or litigation matters involving the Company or its property as of March 28, 2026, that we believe would have a material adverse effect on our consolidated financial position or cash flows, although they could have a material adverse effect on our operating results for a particular reporting period.
Steves & Sons, Inc. v JELD-WEN, Inc. – We sell molded door skins to certain customers pursuant to long-term contracts, and these customers in turn use the molded door skins to manufacture interior doors and compete directly against us in the marketplace. We gave notice of termination of one of these contracts and, on June 29, 2016, the counterparty to the agreement, Steves filed a claim against JWI in the U.S. District Court for the Eastern District of Virginia, Richmond Division (the “Eastern District of Virginia”). The complaint alleged that our acquisition of CMI, a competitor in the molded door skins market, together with subsequent price increases and other alleged acts and omissions, violated antitrust laws, and constituted a breach of contract and breach of warranty. Specifically, the complaint alleged that our acquisition of CMI substantially lessened competition in the molded door skins market. The complaint sought declaratory relief, ordinary and treble damages, and injunctive relief, including divestiture of certain assets acquired in the CMI acquisition.
In February 2018, a jury in the Eastern District of Virginia returned a verdict that was unfavorable to JWI with respect to Steves’ claims that our acquisition of CMI violated Section 7 of the Clayton Act and found that JWI breached the supply agreement between the parties (the “Original Action”). The verdict awarded Steves $12.2 million for past damages under both the Clayton Act and breach of contract claims and $46.5 million in future lost profits under the Clayton Act claim.
During the course of the proceedings in the Eastern District of Virginia, we discovered certain facts that led us to conclude that Steves, its principals, and certain former employees of the Company had misappropriated Company trade secrets, violated the terms of various agreements between the Company and those parties, and violated other laws. On May 11, 2018, a jury in the Eastern District of Virginia returned a verdict on our trade secrets claims against Steves and awarded damages in the amount of $1.2 million. The presiding judge entered a judgment in our favor for those damages, and the entire amount has been paid by Steves. On August 16, 2019, the presiding judge granted Steves’ request for an injunction, prohibiting us from pursuing certain claims against individual defendants pending in Bexar County, Texas (the “Steves Texas Trade Secret Theft Action”). On September 11, 2019, JWI filed a notice of appeal of the Eastern District of Virginia’s injunction to the Fourth Circuit Court of Appeals (the “Fourth Circuit”).
On March 13, 2019, the presiding judge entered an Amended Final Judgment Order in the Original Action, awarding $36.5 million in past damages under the Clayton Act (representing a trebling of the jury’s verdict) and granted divestiture of certain assets acquired in the CMI acquisition, subject to appeal. The judgment also conditionally awarded damages in the event the judgment was overturned on appeal. Specifically, the court awarded $139.4 million as future antitrust damages in the event the divestiture order was overturned on appeal and $9.9 million as past contract damages in the event both the divestiture and antitrust claims were overturned on appeal.
On April 12, 2019, Steves filed a petition requesting an award of its fees and a bill of costs, seeking $28.4 million in attorneys’ fees and $1.7 million in costs in connection with the Original Action. On November 19, 2019, the presiding judge entered an order for further relief awarding Steves an additional $7.1 million in damages for pricing differences from the date of the underlying jury verdict through May 31, 2019 (the “Pricing Action”). We also appealed that ruling. On April 14, 2020, Steves filed a motion for further supplemental relief for pricing differences from the date of the prior order and going forward through the end of the parties’ current supply agreement (the “Future Pricing Action”). We opposed that request for further relief.
JWI filed a supersedeas bond and notice of appeal of the judgment, which was heard by the Fourth Circuit on May 29, 2020. On February 18, 2021, the Fourth Circuit issued its decision on appeal in the Original Action, affirming the Amended Final Judgment Order in part and vacating and remanding in part. The Fourth Circuit vacated the Eastern District of Virginia’s alternative $139.4 million lost-profits award, holding that award was premature because Steves has not suffered the purported injury on which its claim for future lost profits rests. The Fourth Circuit also vacated the Eastern District of Virginia’s judgment for Sam Steves, Edward Steves, and John Pierce on JWI’s trade secrets claims. The Fourth Circuit affirmed the Eastern District of Virginia’s finding of antitrust injury and its award of $36.5 million in past antitrust damages. It also affirmed the Eastern District of Virginia’s divestiture order, while clarifying that JWI retains the right to challenge the terms of any divestiture, including whether a sale to any particular buyer will serve the public interest, and made clear that the Eastern District of Virginia may need to revisit its divestiture order if the special master who has been appointed by the presiding judge cannot locate a satisfactory buyer. JWI then filed a motion for rehearing en banc with the Fourth Circuit that was denied on March 22, 2021.
On May 1, 2024, JWI filed a motion to modify the Amended Final Judgment (the “Motion”) with the Eastern District of Virginia to vacate all court orders requiring divestiture of the Company’s Towanda operations and certain related assets (“Towanda”) considering changed industry and market factors and conditions. The court-mandated divestiture process continued while the court reviewed the Motion. On October 25, 2024, the Special Master submitted a Report and Recommendation to the court recommending that the court approve the divestiture of Towanda to Woodgrain Inc. (“Woodgrain”) for approximately $115 million, subject to customary closing adjustments. On November 14, 2024, JWI and Steves each filed certain objections to the Report and Recommendation. On December 13, 2024, the court adopted the Special Master’s Report and Recommendation, denying JWI’s Motion, overruling JWI’s objections, and sustaining in part and overruling in part Steves’ objections. The court-ordered divestiture closed on January 17, 2025. On February 6, 2025, JELD-WEN filed a notice of appeal (the “Appeal”). The parties’ appellate briefing was completed on September 3, 2025, and oral argument was held on January 29, 2026.
During the pendency of the Original Action, on February 14, 2020, Steves filed a complaint and motion for preliminary injunction in the Eastern District of Virginia alleging that we breached the long-term supply agreement between the parties, including, among other claims, by incorrectly calculating the allocation of door skins owed to Steves (the “Allocation Action”). Steves sought an additional allotment of door skins and damages for violation of antitrust laws, tortious interference, and breach of contract. On April 10, 2020, the presiding judge granted Steves’ motion for preliminary injunction, and the parties settled the issues underlying the preliminary injunction on April 30, 2020, and the Company reserved the right to appeal the ruling in the Fourth Circuit. The Company believed all the claims lacked merit and moved to dismiss the antitrust and tortious interference claims.
On June 2, 2020, we entered into a settlement agreement with Steves to resolve the Pricing Action, the Future Pricing Action, and the Allocation Action. As a result of the settlement, Steves filed a notice of satisfaction of judgment in the Pricing Action, withdrew its Future Pricing Action with prejudice, and filed a stipulated dismissal with prejudice in the Allocation Action. The Company also withdrew its appeal of the Pricing Action. The parties agreed to bear their own respective attorneys’ fees and costs in these actions. In partial consideration of the settlement, JWI and Steves entered into an amended supply agreement satisfactory to both parties that, by its terms, ended on September 10, 2021. This settlement had no effect on the Original Action between the parties except to agree that certain specific terms of the Amended Final Judgment Order in the Original Action would apply to the amended supply agreement during the pendency of the appeal of the Original Action. On April 2, 2021, JWI and Steves filed a stipulation regarding the amended supply agreement in the Original Action, stating that regardless of whether the case remains on appeal as of September 10, 2021, and absent further order of the court, the amended supply agreement would be extended until the divestiture of Towanda is complete and Steves’ new supply agreement with the company that acquires Towanda is in effect.
On October 7, 2021, we entered into a settlement agreement with Steves to resolve the following: (i) Steves’ past and any future claims for attorneys’ fees, expenses, and costs in connection with the Original Action, except that Steves and JWI each reserved the right to seek attorneys’ fees arising out of any challenge of the divestiture process or the final divestiture order; (ii) the Steves Texas Trade Secret Theft Action and the related Fourth Circuit appeal of the Eastern District of Virginia’s injunction in the Original Action; (iii) the past damages award in the Original Action; and (iv) any and all claims and counterclaims, known or unknown, that were asserted or could have been asserted against each other from the beginning of time through the date of the settlement agreement. As a result of the settlement, the parties filed a stipulated notice of satisfaction of the past antitrust damages judgment and a stipulated notice of settlement of Steves’ claim for attorneys’ fees, expenses, and costs against JWI in the Original Action, and Steves filed a notice of withdrawal of its motion for attorneys’ fees and expenses and bill of costs in the Original Action. The Company also filed a notice of dismissal with prejudice and agreed to take no judgment in the Steves Texas Trade Secret Theft Action, and the parties filed a joint agreement for dismissal of the injunction appeal in the Fourth Circuit. On November 3, 2021, we paid $66.4 million to Steves under the settlement agreement.
On March 30, 2026, we entered into a confidential settlement agreement with Steves to resolve the Original Action, including the Appeal, and certain other claims. As a result of the settlement: (i) on April 2, 2026, Steves withdrew its pending Motion to Enforce the Amended Final Judgment, which was filed on December 29, 2025; (ii) on April 2, 2026, the parties and Woodgrain filed a joint stipulation of voluntary dismissal of the Appeal in the Fourth Circuit; and (iii) on April 10, 2026, the parties and Woodgrain filed a joint statement of position in the Eastern District of Virginia that there are no other matters pending before the court in this action and that the action may be administratively closed, with each party bearing its own costs related to this action. On April 2, 2026, the Fourth Circuit granted the parties’ motion to dismiss the Appeal and issued its mandate. On April 16, 2026, the Eastern District of Virginia closed the Original Action. As a result of the settlement, we recognized legal settlement expense of $8.5 million in the three months ended March 28, 2026, recorded in SG&A in the accompanying unaudited condensed consolidated statement of operations.
We continue to believe the claims in the settled actions lacked merit and made no admission of liability in these matters.
Wood Moulding and Millworks Products (“WMMP”) Anti-dumping and Countervailing Duty (“AD/CVD”) Investigation – On June 9, 2025, the United States Department of Commerce issued its Preliminary Results in its administrative review of wood moulding and millwork products imported from China between January 1, 2023, and January 31, 2024. The Preliminary Results found that the Company could be responsible for additional AD/CVD duties for the applicable time period. The Company and other interested parties have filed additional case briefs with the Department of Commerce arguing that the Preliminary Results are inconsistent with any evidence of products being imported for less than normal value. The Company received final rulings in February 2026. As a result of these final rulings, the Company recognized expense of $2.1 million in the year ended December 31, 2025, which was recorded within other expense (income) in the consolidated statement of operations.
We have evaluated the claims against us and recorded provisions based on management’s judgment about the probable outcome of the litigation and have included our estimates in accrued expenses in the accompanying unaudited condensed consolidated balance sheets. Refer to Note 8 - Accrued Expenses and Other Current Liabilities to our unaudited condensed consolidated financial statements included in this Form 10-Q for more information. While we expect a favorable resolution to these matters, the dispute resolution process could be lengthy, and if the plaintiffs were to prevail completely or substantially in the respective matters described above, such an outcome could have a material adverse effect on our operating results, consolidated financial position, or cash flows.
Self-Insured Risk – We self-insure substantially all our domestic business liability risks including general liability, product liability, warranty, personal injury, auto liability, workers’ compensation, and employee medical benefits. Excess insurance policies from independent insurance companies generally cover exposures between $5.0 million and $200.0 million for domestic product liability risk and exposures between $3.0 million and $200.0 million for auto, general liability, personal injury, and workers’ compensation. We estimate our provision for self-insured losses based upon an evaluation of current claim exposure and historical loss experience. Actual self-insurance losses may vary significantly from these estimates. At March 28, 2026 and December 31, 2025, our accrued liability for self-insured risks was $73.9 million and $76.0 million, respectively.
Indemnifications – At March 28, 2026, we had commitments related to certain representations made in contracts for sale of businesses or property, including the divestiture of JW Australia and the court-ordered divestiture of Towanda. Our indemnity obligations under the relevant agreements may be limited in terms of time, amount, or scope. These representations primarily relate to past actions such as responsibility for transfer taxes if they should be claimed, and the adequacy of recorded liabilities, warranty matters, employment benefit plans, income tax matters, or environmental exposures. As it relates to certain income tax related liabilities, the relevant agreements may not provide any cap for such liabilities, and the period in which we would be liable would lapse upon expiration of the statute of limitation for assessment of the underlying taxes. Because of the conditional nature of these obligations and the unique facts and circumstances involved in each agreement, we are unable to reasonably estimate the potential maximum exposure associated with these items. We are not aware of any material amounts claimed or expected to be claimed under these indemnities.
From time to time and in limited geographic areas, we have entered into agreements for the sale of our products to certain customers that provide additional indemnifications for liabilities arising from construction or product defects. We cannot estimate the potential magnitude of such exposures, but to the extent specific liabilities have been identified related to product sales, liabilities have been provided in the warranty accrual in the accompanying unaudited condensed consolidated balance sheets.
Other Financing Arrangements – At times we are required to provide letters of credit, surety bonds, or guarantees to meet various performance, legal, warranty, environmental, workers compensation, licensing, utility, and governmental requirements. Stand-by letters of credit are provided to certain customers and counterparties in the ordinary course of business as credit support for contractual performance guarantees, advanced payments received from customers, and future funding commitments. The stated values of these letters of credit agreements, surety bonds, and guarantees were $75.0 million and $74.5 million at March 28, 2026 and December 31, 2025, respectively.
Environmental Contingencies – We periodically incur environmental liabilities associated with remediating our current and former manufacturing sites as well as penalties for not complying with environmental rules and regulations. We record a liability for remediation costs when it is probable that we will be responsible for such costs, and the costs can be reasonably estimated. These environmental liabilities are estimated based on current available facts and current laws and regulations. Accordingly, it is likely that adjustments to the estimated liabilities will be necessary as additional information becomes available. Short-term environmental liabilities and settlements are recorded in accrued expenses and other current liabilities in the accompanying unaudited condensed consolidated balance sheets and totaled $7.5 million and $7.6 million at March 28, 2026 and December 31, 2025, respectively. Long-term environmental liabilities are recorded in deferred credits and other liabilities in the accompanying unaudited condensed consolidated balance sheets and totaled $13.4 million at March 28, 2026 and December 31, 2025.
Everett, Washington WADOE Action – In 2007, we were identified by the WADOE as a PLP with respect to our former manufacturing site in Everett, Washington. In 2008, we entered into an Agreed Order with the WADOE to assess historic environmental contamination and remediation feasibility at the site. As part of the order, we agreed to develop a CAP, arising from the feasibility assessment. In December 2020, we submitted to the WADOE a draft feasibility assessment with an array of remedial alternatives, which we considered substantially complete. During 2021, several comment rounds were completed as well as the identification of the Port of Everett and W&W Everett Investment LLC as additional PLPs, with respect to this matter with each PLP being jointly and severally liable for the cleanup costs. The WADOE received the final feasibility assessment on December 31, 2021, containing various remedial alternatives with its preferred remedial alternatives totaling $23.4 million. Based on this study, we determined our range of possible outcomes to be $11.8 million to $33.4 million. On March 1, 2022, we delivered a draft CAP consistent with the preferred alternatives which was approved by WADOE in August 2023. The existing Agreed Order of 2008 was also modified with WADOE in July 2023 to support the development of the associated CAP investigation, sampling, and design components. With additional information gathered from the CAP investigation during 2024, we determined the total range of possible remediation cost outcomes to be between $17.4 million to $33.6 million. We retained a provision of $11.8 million within our financial statements which considers the range of possible outcome costs and potential allocation of responsibility between the identified PLPs, both of which could vary materially from our estimates. In December 2025, as the scope and timing of the remedial work was further refined, we determined the total range of possible remediation cost outcomes remained between $17.4 million and $33.6 million, but that the most likely possible remediation cost outcome is approximately $21.0 million. The Company adjusted the provision within its financial statements to that amount and recognized a long-term receivable of $5.6 million within other assets in the accompanying unaudited condensed consolidated balance sheet related to loss recoveries. This provision may ultimately be offset in whole or in part by recoveries from PLPs or insurance proceeds.
v3.26.1
Supplemental Cash Flow Information
 3 Months Ended
Mar. 28, 2026
Supplemental Cash Flow Elements [Abstract]  
Supplemental Cash Flow Information Supplemental Cash Flow Information
Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Cash Operating Activities:
Operating leases$15,829 $12,403 
Interest payments on financing lease obligations184 194 
Cash paid for amounts included in the measurement of lease liabilities$16,013 $12,597 
Cash Investing Activities:
Purchases of securities for deferred compensation plan(174)(273)
Change in securities for deferred compensation plan$(174)$(273)
Cash received on notes receivable5 7 
Change in notes receivable$5 $7 
Non-cash Investing Activities:
Property, equipment and intangibles purchased in accounts payable$3,599 $7,417 
Property, equipment and intangibles purchased with debt3,081 2,653 
Customer accounts receivable converted to notes receivable 289 3 
Cash Financing Activities:
Borrowings on long-term debt$74,004 $— 
Payments of long-term debt(41,692)(5,254)
Payments of debt issuance and extinguishment costs, including underwriting fees— (810)
Change in long-term debt and payments of debt extinguishment costs$32,312 $(6,064)
Cash paid for amounts included in the measurement of finance lease liabilities $867 $284 
Non-cash Financing Activities:
Debt issuance costs in accounts payable$— $245 
Shares surrendered for tax obligations for employee share-based transactions in accrued liabilities23 623 
Reclassification of share-based awards to liability in accrued liabilities90 — 
Other Supplemental Cash Flow Information:
Cash taxes paid, net of refunds$3,570 $8,805 
Cash interest paid16,599 17,209 
v3.26.1
Insider Trading Arrangements
 3 Months Ended
Mar. 28, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.26.1
Description of Company and Summary of Significant Accounting Policies (Policies)
 3 Months Ended
Mar. 28, 2026
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation – The accompanying unaudited condensed consolidated financial statements as of March 28, 2026, and for the three months ended March 28, 2026, and March 29, 2025, have been prepared in accordance with GAAP for interim financial information and pursuant to the rules and regulations of the SEC. In the opinion of management, the unaudited condensed consolidated financial statements have been prepared on the same basis as the audited financial statements and include all adjustments, consisting only of normal recurring adjustments, necessary for the fair statement of the Company’s financial position for the periods presented. The results for the three months ended March 28, 2026, are not necessarily indicative of the results to be expected for the year ending December 31, 2026, or any other period. The accompanying unaudited condensed consolidated balance sheet as of December 31, 2025, was derived from audited financial statements included in our Annual Report on Form 10-K. The accompanying unaudited condensed consolidated financial statements do not include all the information and footnotes required by GAAP for annual financial statements. Accordingly, they should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025.
All U.S. dollar and other currency amounts, except share and per share amounts, are presented in thousands unless otherwise noted.
Fiscal Year
Fiscal Year – We operate on a fiscal calendar year, and each interim quarter is comprised of two 4-week periods and one 5-week period, with each week ending on a Saturday. Our fiscal year always begins on January 1 and ends on December 31. As a result, our first and fourth quarters may have more, or fewer days included than a traditional 91-day fiscal quarter.
Use of Estimates
Use of Estimates – The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets including goodwill (prior to impairment) and other intangible assets, employee benefit obligations, income tax uncertainties, contingent assets and liabilities, provisions for bad debt, inventory, warranty liabilities, legal claims, valuation of derivatives, environmental remediation, and claims relating to self-insurance. Actual results could differ due to the uncertainty inherent in these estimates.
Warranty Accrual Warranty Accrual – In Q4 2025, we corrected our warranty accrual calculation resulting in an additional $6.7 million of expense that should have been recognized in our prior interim periods in 2025. We have evaluated the impact on prior interim periods and concluded that the amounts were not material.
Recent Accounting Standards Not Yet Adopted
Recent Accounting Standards Not Yet Adopted – In November 2024, the FASB issued ASU 2024-03, Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses. ASU 2024-03 requires disclosure of disaggregated information about specific natural expense categories underlying certain income statement expense line items that are considered relevant. The FASB also issued ASU 2025-01, Expense Disaggregation Disclosures: Clarifying the Effective Date, which clarifies the adoption date of ASU 2024-03 as annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted, and the guidance should be applied either prospectively to financial statements issued for reporting dates after the effective date or retrospectively to any or all prior periods presented in the financial statements. We are currently evaluating the impact of this guidance on the Company’s disclosures.
In September 2025, the FASB issued ASU 2025-06, Targeted Improvements to the Accounting for Internal-Use Software. ASU 2025-06 amends certain aspects of the accounting for and disclosure of internal-use software costs under ASC 350-40. The guidance is effective for interim and annual periods beginning after December 15, 2027, with early adoption permitted, and can be applied prospectively, retrospectively, or with a modified transition approach. We are currently evaluating the impact of this guidance on the Company’s disclosures.
We have considered the applicability and impact of all ASUs. We have assessed the ASUs not listed above and determined that they were either not applicable or were not expected to have a material impact on our unaudited condensed consolidated financial statements.
v3.26.1
Inventories (Tables)
 3 Months Ended
Mar. 28, 2026
Inventory Disclosure [Abstract]  
Schedule of Inventories
Inventories are stated at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor, and manufacturing overhead costs.
(amounts in thousands)March 28, 2026December 31, 2025
Raw materials$360,836 $365,418 
Work in process25,680 21,988 
Finished goods89,102 85,642 
Inventory valuation reserves(29,427)(28,946)
Total inventories$446,191 $444,102 
v3.26.1
Property and Equipment, Net (Tables)
 3 Months Ended
Mar. 28, 2026
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment
(amounts in thousands)March 28, 2026December 31, 2025
Property and equipment$2,102,986 $2,102,835 
Accumulated depreciation(1,378,699)(1,374,390)
Total property and equipment, net$724,287 $728,445 
Depreciation expense was recorded as follows:
Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Cost of sales$21,586 $19,172 
Selling, general, and administrative1,266 1,178 
Total depreciation expense$22,852 $20,350 
v3.26.1
Intangible Assets, Net (Tables)
 3 Months Ended
Mar. 28, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Finite-Lived Intangible Assets
The cost and accumulated amortization values of our intangible assets were as follows:
March 28, 2026
(amounts in thousands)CostAccumulated
Amortization		Net
Book Value
Customer relationships and agreements$126,427 $(107,018)$19,409 
Software88,518 (41,017)47,501 
Trademarks and trade names32,641 (14,829)17,812 
Patents, licenses and rights15,412 (7,042)8,370 
Total amortizable intangibles$262,998 $(169,906)$93,092 
December 31, 2025
(amounts in thousands)CostAccumulated
Amortization		Net
Book Value
Customer relationships and agreements$127,659 $(106,339)$21,320 
Software89,225 (40,708)48,517 
Trademarks and trade names32,804 (14,510)18,294 
Patents, licenses and rights14,931 (6,732)8,199 
Total amortizable intangibles$264,619 $(168,289)$96,330 
Schedule of Finite-lived Intangible Assets Amortization Expense
Amortization expense was recorded as follows:
Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Amortization expense$5,051 $5,493 
v3.26.1
Accrued Expenses and Other Current Liabilities (Tables)
 3 Months Ended
Mar. 28, 2026
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:
(amounts in thousands)March 28, 2026December 31, 2025
Accrued sales and advertising rebates$59,740 $72,840 
Current portion of operating lease liability36,898 33,761 
Non-income related taxes22,115 18,786 
Current portion of warranty liability (Note 9)
20,554 21,321 
Accrued expenses18,329 17,958 
Accrued freight17,129 14,779 
Current portion of accrued claim costs relating to self-insurance programs14,446 15,166 
Accrued interest payable9,633 9,224 
Legal claims provision (Note 20)
9,232 3,156 
Deferred revenue and customer deposits3,988 4,946 
Current portion of restructuring accrual (Note 16)
3,739 9,003 
Accrued income taxes payable1,661 1,583 
Current portion of derivative liability (Note 18)
783 624 
Total accrued expenses and other current liabilities$218,247 $223,147 
v3.26.1
Warranty Liability (Tables)
 3 Months Ended
Mar. 28, 2026
Product Warranties Disclosures [Abstract]  
Schedule of Analysis of Warranty Liability
An analysis of our warranty liability is as follows:
(amounts in thousands)March 28, 2026March 29, 2025
Balance as of January 1,$40,676 $47,289 
Current period charges4,932 2,943 
Payments(5,714)(5,820)
Currency translation(127)295 
Balance at period end39,766 44,707 
Current portion(20,554)(18,759)
Long-term portion$19,212 $25,948 
v3.26.1
Long-Term Debt (Tables)
 3 Months Ended
Mar. 28, 2026
Debt Disclosure [Abstract]  
Schedule of Long-Term Debt Instruments
Our long-term debt, net of unamortized debt issuance costs and original issue discounts, consisted of the following:
(amounts in thousands)March 28, 2026 Interest RatesMarch 28, 2026December 31, 2025
Revolving Credit Facility
5.03%(1)
$40,000 $— 
Senior Notes due December 2027
4.88%
400,000 400,000 
Term Loan Facility due July 2028
5.79%(1)
375,525 375,525 
Senior Notes due September 2032
7.00%
350,000 350,000 
Finance leases and other financing arrangements
1.00% - 8.28%(1)
49,661 54,458 
Total debt$1,215,186 $1,179,983 
Unamortized debt issuance costs and original issue discounts(6,224)(6,679)
Current maturities of long-term debt(19,526)(23,690)
Long-term debt$1,189,436 $1,149,614 
(1)Term Loan Facility due July 2028, Revolving Credit Facility, and certain finance leases and other financing arrangements are subject to variable interest rates.
v3.26.1
Segment Information (Tables)
 3 Months Ended
Mar. 28, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reportable Segments, by Segment
Three Months Ended March 28, 2026
(amounts in thousands)North
America 		EuropeTotal
Revenues from external customers$452,713 $269,412 $722,125 
Intersegment net revenues— — — 
Total segment net revenues$452,713 $269,412 $722,125 
Reconciliation of Revenue
Elimination of intersegment net revenues— 
Total consolidated net revenues$722,125 
Less:
Adjusted cost of sales$408,712 $217,256 $625,968 
Adjusted selling, general and administrative58,964 52,196 111,160 
Other segment items(1)
(18,582)(7,116)(25,698)
Adjusted EBITDA$3,619 $7,076 $10,695 
Total Reportable Segment Adjusted EBITDA$10,695 
Less:
Depreciation and amortization29,370 
Interest expense, net17,203 
Corporate and unallocated costs4,554 
Special items:
Net legal and professional expenses and settlements12,767 
Restructuring and asset-related charges, net1,979 
M&A related costs, net7,599 
Share-based compensation expense3,682 
Other special items(2)
7,009 
Loss, before tax$(73,468)
(1)Other segment items included depreciation and amortization, which are included as a component of the significant expense categories regularly provided to the CODM above but are not included in the measure of segment profit, as well as other items, which are excluded from the categories regularly provided to the CODM, which primarily included:
North America - Foreign currency losses.
Europe - Foreign currency losses and pension expense.
(2)Other special items not core to ongoing business activity included an impairment of $3.1 million in our North America reporting unit as a result of reviews performed in connection with our North America equipment capacity optimization.
Three Months Ended March 28, 2026
(amounts in thousands)North
America 		EuropeCorporate
and
Unallocated
Costs		Total
Consolidated
Depreciation and amortization
$18,829 $8,384 $2,157 $29,370 
Capital expenditures15,317 9,824 937 26,078 
Segment assets
1,263,792 683,981 129,495 2,077,268 
Three Months Ended March 29, 2025
(amounts in thousands)North
America 		EuropeTotal
Revenues from external customers$530,561 $245,445 $776,006 
Intersegment net revenues33 489 522 
Total segment net revenues$530,594 $245,934 $776,528 
Reconciliation of Revenue
Elimination of intersegment net revenues(522)
Total consolidated net revenues$776,006 
Less:
Adjusted cost of sales$465,648 $197,854 $663,502 
Adjusted selling, general and administrative69,499 44,261 113,760 
Other segment items(1)
(20,110)(7,327)(27,437)
Adjusted EBITDA$15,524 $10,657 $26,181 
Total Reportable Segment Adjusted EBITDA$26,181 
Less:
Depreciation and amortization27,295 
Interest expense, net14,918 
Corporate and unallocated costs4,312 
Special items:
Net legal and professional expenses and settlements11,882 
Goodwill impairment137,721 
Restructuring and asset-related charges, net14,546 
M&A related costs, net(613)
Net gain on sale of business, property, and equipment(653)
Loss on extinguishment and refinancing of debt237 
Share-based compensation expense3,228 
Other special items2,828 
Loss, before tax$(189,520)
(1)Other segment items included depreciation and amortization, which are included as a component of the significant expense categories regularly provided to the CODM above but are not included in the measure of segment profit, as well as other items, which are excluded from the categories regularly provided to the CODM, which primarily included:
North America - Refund of deposits for antidumping and countervailing duties on wood mouldings and millwork products purchased from China from 2022 to 2023.
Europe - Pension expense and foreign currency losses.
Three Months Ended March 29, 2025
(amounts in thousands)North
America 		EuropeCorporate
and
Unallocated
Costs		Total
Consolidated
Depreciation and amortization
$17,325 $7,565 $2,405 $27,295 
Capital expenditures27,736 10,290 3,928 41,954 
Segment assets
1,349,336 774,988 294,591 2,418,915 
v3.26.1
Loss Per Share (Tables)
 3 Months Ended
Mar. 28, 2026
Earnings Per Share [Abstract]  
Schedule of Weighted Average Shares Outstanding, Basic and Diluted
The basic and diluted loss per share calculations were determined based on the following share data:
Three Months Ended
March 28, 2026March 29, 2025
Weighted average outstanding shares of Common Stock basic85,803,503 84,917,294 
Restricted stock units, performance share units and options to purchase Common Stock— — 
Weighted average outstanding shares of Common Stock diluted85,803,503 84,917,294 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table provides the securities that could potentially dilute basic earnings per share in the future but were not included in the computation of diluted income per share as their inclusion would be anti-dilutive:
Three Months Ended
March 28, 2026March 29, 2025
Common Stock options1,289,560 1,558,883 
Restricted stock units2,295,706 1,205,152 
Performance share units573,306 64,781 
v3.26.1
Share-Based Compensation (Tables)
 3 Months Ended
Mar. 28, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The activity under our incentive plans for the periods presented is reflected in the following tables:
Three Months Ended
March 28, 2026March 29, 2025
SharesWeighted Average Exercise Price Per ShareSharesWeighted Average Exercise Price Per Share
Options granted— $— 536,432 $9.05 
Options cancelled5,568 $33.34 41,989 $22.28 
SharesWeighted Average Grant Date Fair ValueSharesWeighted Average Grant Date Fair Value
RSUs granted1,150,708 $2.72 1,386,301 $9.02 
PSUs granted— $— 620,673 $9.47 
PSUs performance adjustment(181,281)$— — $— 
Schedule of RSU and PSU Activity
The activity under our incentive plans for the periods presented is reflected in the following tables:
Three Months Ended
March 28, 2026March 29, 2025
SharesWeighted Average Exercise Price Per ShareSharesWeighted Average Exercise Price Per Share
Options granted— $— 536,432 $9.05 
Options cancelled5,568 $33.34 41,989 $22.28 
SharesWeighted Average Grant Date Fair ValueSharesWeighted Average Grant Date Fair Value
RSUs granted1,150,708 $2.72 1,386,301 $9.02 
PSUs granted— $— 620,673 $9.47 
PSUs performance adjustment(181,281)$— — $— 
v3.26.1
Restructuring and Asset-Related Charges, Net (Tables)
 3 Months Ended
Mar. 28, 2026
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Asset Related Costs
(amounts in thousands)North
America 		EuropeCorporate
and
Unallocated
Costs		Total
Consolidated
Three Months Ended March 28, 2026
Restructuring severance and employee-related charges, net$456 $81 $33 $570 
Other restructuring associated costs, net336 977 — 1,313 
Asset-related charges, net— 96 — 96 
Other restructuring associated costs and asset-related charges, net336 1,073 — 1,409 
Total restructuring and asset-related charges, net$792 $1,154 $33 $1,979 
Three Months Ended March 29, 2025
Restructuring severance and employee-related charges, net(1)
$10,019 $1,850 $736 $12,605 
Other restructuring associated costs, net644 1,131 — 1,775 
Asset-related charges, net— 166 — 166 
Other restructuring associated costs and asset-related charges, net644 1,297 — 1,941 
Total restructuring and asset-related charges, net$10,663 $3,147 $736 $14,546 
(1)In the first quarter of fiscal 2025, the Company implemented a reduction in force, which was substantially complete as of March 29, 2025. The charges incurred in the three months ended March 29, 2025, were included in restructuring and asset-related charges, net in the accompanying unaudited condensed consolidated statement of operations and include $0.7 million related to Corporate.
Costs and cash outlays associated with the plans are as follows:
Total Estimated CostsCumulative Costs to-dateCosts in the Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Restructuring severance and employee-related charges, net(1)
$36,600 $35,009 $456 $10,019 
Other restructuring associated costs, net(1)
17,700 12,820 336 644 
Product-related cash charges(2)
6,700 6,719 — 134 
Total cash charges$61,000 $54,548 $792 $10,797 
Asset-related charges, net(1)
24,900 23,974 — — 
Inventory and other product-related non-cash charges, net(3)
9,300 9,061 (82)1,121 
Total non-cash charges$34,200 $33,035 $(82)$1,121 
Total costs$95,200 $87,583 $710 $11,918 
Total cash outlays(4)
$67,600 $60,092 $3,422 $5,556 
(1)The charges incurred in the three months ended March 28, 2026 and March 29, 2025, were included in restructuring and asset-related charges, net in the accompanying unaudited condensed consolidated statements of operations.
(2)The product-related cash charges incurred in the three months ended March 29, 2025, were detrimental to net sales in the accompanying unaudited condensed consolidated statement of operations.
(3)The inventory and other product-related non-cash charges, net in the three months ended March 28, 2026 and March 29, 2025, were included in cost of sales in the accompanying unaudited condensed consolidated statement of operations.
(4)Total cash outlays include $5.5 million of cash payments related to debt repayment for financed equipment, and a $0.9 million lease termination fee.
Costs and cash outlays associated with the plans are as follows:
Total Estimated CostsCumulative Costs to-dateCosts in the Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Restructuring severance and employee-related charges, net(1)
$32,000 $30,969 $81 $1,850 
Other restructuring associated costs, net(1)
17,000 14,706 977 1,131 
Total cash charges$49,000 $45,675 $1,058 $2,981 
Asset-related charges, net(1)
2,700 1,880 96 166 
Total costs$51,700 $47,555 $1,154 $3,147 
Total cash outlays$49,000 $43,570 $2,843 $4,600 
(1)The charges incurred in the three months ended March 28, 2026 and March 29, 2025, were included in restructuring and asset-related charges, net in the accompanying unaudited condensed consolidated statements of operations.
Schedule of Restructuring Reserve by Type of Cost
The following is a summary of the restructuring accruals recorded, and charges incurred:
(amounts in thousands)March 28, 2026December 31, 2025
Balance as of January 1,$9,003 $7,605 
Current period charges, net1,884 41,362 
Payments(7,096)(40,508)
Currency translation(52)544 
Balance at period end$3,739 $9,003 
v3.26.1
Other Expense (Income) (Tables)
 3 Months Ended
Mar. 28, 2026
Other Income and Expenses [Abstract]  
Schedule of Other Expense (Income)
The table below summarizes the amounts included in other expense (income) in the accompanying unaudited condensed consolidated statements of operations:
Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Foreign currency losses (gains), net$1,075 $(209)
Pension expense494 867 
Governmental assistance(5)(3)
Cash received on real estate investment(1)
— (7,567)
Income from refund of deposits for China antidumping and countervailing duties, net(2)
— (2,859)
Gains on commodity derivatives— (361)
Other items, net(521)(454)
Total other expense (income)
$1,043 $(10,586)
(1)Cash received on real estate investment represents recovery of an investment in real estate development in Mexico.
(2)Represents income from the refund of deposits for antidumping and countervailing duties on wood mouldings and millwork products purchased from China from 2020 to 2023.
v3.26.1
Derivative Financial Instruments (Tables)
 3 Months Ended
Mar. 28, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The fair values of derivative instruments held are as follows:
Derivative Assets
(amounts in thousands)Balance Sheet LocationMarch 28, 2026December 31, 2025
Foreign currency forward contractsOther current assets$442 $539 
Derivative Liabilities
(amounts in thousands)Balance Sheet LocationMarch 28, 2026December 31, 2025
Derivatives designated as hedging instruments:
Interest rate contractsAccrued expenses and other current liabilities— 41 
Derivatives not designated as hedging instruments:
Foreign currency forward contractsAccrued expenses and other current liabilities$783 $583 
Schedule of Derivative Instruments, Gain (Loss)
The effect of derivative instruments in the unaudited condensed consolidated statements of operations is as follows:
Location of (Loss) Gain Recognized in Condensed Consolidated Statements of Operations
Amount of (Loss) Gain Recognized in Earnings on Derivatives
Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Derivatives designated as hedging instruments:
Foreign currency forward contractsCost of sales$(106)$47 
Commodity contractsCost of sales— 35 
Interest rate contractsInterest expense, net(39)— 
Derivatives not designated as hedging instruments:
Foreign currency forward contractsOther expense (income)(1,120)(752)
Commodity contractsOther expense (income)— 361 
Total$(1,265)$(309)
v3.26.1
Fair Value of Financial Instruments (Tables)
 3 Months Ended
Mar. 28, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The recorded carrying amounts and fair values of these instruments were as follows:
March 28, 2026
(amounts in thousands)Carrying AmountTotal
Fair Value		Level 1Level 2Level 3
Assets measured at NAV(1)
Assets:
Cash equivalents$18,268 $18,268 $18,268 $— $— $— 
Derivative assets, recorded in other current assets442 442 — 442 — — 
Deferred compensation plan assets, recorded in other assets5,163 5,163 — 5,163 — — 
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt$1,215,186 $843,673 $— $843,673 $— $— 
Derivative liabilities, recorded in accrued expenses and other current liabilities783 783 — 783 — — 
Deferred compensation plan liabilities, recorded in deferred credits and other liabilities5,170 5,170 — 5,170 — — 
December 31, 2025
(amounts in thousands)Carrying AmountTotal
Fair Value		Level 1Level 2Level 3
Assets measured at NAV(1)
Assets:
Cash equivalents$65,386 $65,386 $65,386 $— $— $— 
Derivative assets, recorded in other current assets539 539 — 539 — — 
Deferred compensation plan assets, recorded in other assets5,773 5,773 — 5,773 — — 
Liabilities:
Debt, recorded in long-term debt and current maturities of long-term debt$1,179,983 $974,915 $— $974,915 $— $— 
Derivative liabilities, recorded in accrued expenses and other current liabilities624 624 — 624 — — 
Deferred compensation plan liabilities, recorded in deferred credits and other liabilities5,778 5,778 — 5,778 — — 
v3.26.1
Supplemental Cash Flow Information (Tables)
 3 Months Ended
Mar. 28, 2026
Supplemental Cash Flow Elements [Abstract]  
Schedule of Cash Flow, Supplemental Disclosures
Three Months Ended
(amounts in thousands)March 28, 2026March 29, 2025
Cash Operating Activities:
Operating leases$15,829 $12,403 
Interest payments on financing lease obligations184 194 
Cash paid for amounts included in the measurement of lease liabilities$16,013 $12,597 
Cash Investing Activities:
Purchases of securities for deferred compensation plan(174)(273)
Change in securities for deferred compensation plan$(174)$(273)
Cash received on notes receivable5 7 
Change in notes receivable$5 $7 
Non-cash Investing Activities:
Property, equipment and intangibles purchased in accounts payable$3,599 $7,417 
Property, equipment and intangibles purchased with debt3,081 2,653 
Customer accounts receivable converted to notes receivable 289 3 
Cash Financing Activities:
Borrowings on long-term debt$74,004 $— 
Payments of long-term debt(41,692)(5,254)
Payments of debt issuance and extinguishment costs, including underwriting fees— (810)
Change in long-term debt and payments of debt extinguishment costs$32,312 $(6,064)
Cash paid for amounts included in the measurement of finance lease liabilities $867 $284 
Non-cash Financing Activities:
Debt issuance costs in accounts payable$— $245 
Shares surrendered for tax obligations for employee share-based transactions in accrued liabilities23 623 
Reclassification of share-based awards to liability in accrued liabilities90 — 
Other Supplemental Cash Flow Information:
Cash taxes paid, net of refunds$3,570 $8,805 
Cash interest paid16,599 17,209 
v3.26.1
Description of Company and Summary of Significant Accounting Policies - Narrative (Details)
$ in Millions
 3 Months Ended
Mar. 28, 2026
USD ($)
Accounting Policies [Abstract]  
Additional prior period warranty expense $ 6.7
v3.26.1
Divestiture (Details) - Disposed of by sale - Towanda - USD ($)
$ in Millions
 3 Months Ended
Sep. 27, 2025
Mar. 29, 2025
Jan. 17, 2025
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Adjustment of purchase price   $ 115.0  
Pre-tax gain on the sale   0.7  
Liabilities held for sale     $ 110.8
Property and equipment, net     65.4
Inventory     16.7
Trade receivable     8.8
Lease assets     2.2
Intangible assets     1.5
Goodwill impairment     33.6
Accounts payable     $ 9.2
Tax expense related to gain   $ 8.5  
Valuation allowance expense $ 7.8    
v3.26.1
Accounts Receivable, Net (Details) - USD ($)
$ in Millions
Mar. 28, 2026
Dec. 31, 2025
Receivables [Abstract]    
Allowance for credit losses $ 11.7 $ 11.1
v3.26.1
Inventories (Details) - USD ($)
$ in Thousands
Mar. 28, 2026
Dec. 31, 2025
Inventory Disclosure [Abstract]    
Raw materials $ 360,836 $ 365,418
Work in process 25,680 21,988
Finished goods 89,102 85,642
Inventory valuation reserves (29,427) (28,946)
Total inventories $ 446,191 $ 444,102
v3.26.1
Property and Equipment, Net - Property and Equipment (Details) - USD ($)
$ in Thousands
Mar. 28, 2026
Dec. 31, 2025
Property, Plant and Equipment [Abstract]    
Property and equipment $ 2,102,986 $ 2,102,835
Accumulated depreciation (1,378,699) (1,374,390)
Total property and equipment, net $ 724,287 $ 728,445
v3.26.1
Property and Equipment, Net - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Dec. 31, 2025
Property, Plant and Equipment [Line Items]      
Asset-related charges, net $ 96 $ 166  
Depreciation 22,852 $ 20,350  
Gain (loss) due to currency translations for foreign assets (4,300)   $ (4,300)
Property, Plant and Equipment      
Property, Plant and Equipment [Line Items]      
Asset-related charges, net 3,100    
Depreciation $ 1,200    
v3.26.1
Property and Equipment, Net - Depreciation Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Property, Plant and Equipment [Line Items]    
Total depreciation expense $ 22,852 $ 20,350
Cost of sales    
Property, Plant and Equipment [Line Items]    
Total depreciation expense 21,586 19,172
Selling, general, and administrative    
Property, Plant and Equipment [Line Items]    
Total depreciation expense $ 1,266 $ 1,178
v3.26.1
Goodwill (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Sep. 27, 2025
Mar. 29, 2025
Goodwill [Line Items]      
Restructuring and asset-related charges, net $ 0   $ 137,721
Operating segments | North America      
Goodwill [Line Items]      
Restructuring and asset-related charges, net   $ 196,900 $ 137,700
v3.26.1
Intangible Assets, Net - Cost and Accumulated Amortization (Details) - USD ($)
$ in Thousands
Mar. 28, 2026
Dec. 31, 2025
Finite-Lived Intangible Assets    
Cost $ 262,998 $ 264,619
Accumulated Amortization (169,906) (168,289)
Net Book Value 93,092 96,330
Customer relationships and agreements    
Finite-Lived Intangible Assets    
Cost 126,427 127,659
Accumulated Amortization (107,018) (106,339)
Net Book Value 19,409 21,320
Software    
Finite-Lived Intangible Assets    
Cost 88,518 89,225
Accumulated Amortization (41,017) (40,708)
Net Book Value 47,501 48,517
Trademarks and trade names    
Finite-Lived Intangible Assets    
Cost 32,641 32,804
Accumulated Amortization (14,829) (14,510)
Net Book Value 17,812 18,294
Patents, licenses and rights    
Finite-Lived Intangible Assets    
Cost 15,412 14,931
Accumulated Amortization (7,042) (6,732)
Net Book Value $ 8,370 $ 8,199
v3.26.1
Intangible Assets, Net - Amortization Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense $ 5,051 $ 5,493
v3.26.1
Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Mar. 28, 2026
Dec. 31, 2025
Mar. 29, 2025
Accounts Payable and Accrued Liabilities, Current      
Accrued sales and advertising rebates $ 59,740 $ 72,840  
Current portion of operating lease liability 36,898 33,761  
Non-income related taxes 22,115 18,786  
Current portion of warranty liability (Note 9) 20,554 21,321 $ 18,759
Accrued expenses 18,329 17,958  
Accrued freight 17,129 14,779  
Current portion of accrued claim costs relating to self-insurance programs 14,446 15,166  
Accrued interest payable 9,633 9,224  
Legal claims provision (Note 20) 9,232 3,156  
Deferred revenue and customer deposits 3,988 4,946  
Current portion of restructuring accrual (Note 16) 3,739 9,003  
Accrued income taxes payable 1,661 1,583  
Current portion of derivative liability (Note 18) 783 624  
Total accrued expenses and other current liabilities $ 218,247 $ 223,147  
v3.26.1
Warranty Liability - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Dec. 31, 2025
Mar. 29, 2025
Dec. 31, 2024
Product Warranty Liability        
Accrued warranty liability $ 39,766 $ 40,676 $ 44,707 $ 47,289
Product warranty, discount adjustment 2,800      
North America        
Product Warranty Liability        
Accrued warranty liability $ 35,600      
Minimum        
Product Warranty Liability        
Product warranty term (in years) 1 year      
Product warranty discount rate (as a percent) 3.55%      
Maximum        
Product Warranty Liability        
Product warranty term (in years) 10 years      
Product warranty discount rate (as a percent) 4.19%      
v3.26.1
Warranty Liability - Analysis of Warranty Liability (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Dec. 31, 2025
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease)      
Balance at beginning balance $ 40,676 $ 47,289  
Current period charges 4,932 2,943  
Payments (5,714) (5,820)  
Currency translation (127) 295  
Balance at ending balance 39,766 44,707  
Current portion (20,554) (18,759) $ (21,321)
Long-term portion $ 19,212 $ 25,948  
v3.26.1
Long-Term Debt - Long Term Debt (Details) - USD ($)
$ in Thousands
Mar. 28, 2026
Dec. 31, 2025
Debt Instrument    
Total debt $ 1,215,186 $ 1,179,983
Unamortized debt issuance costs and original issue discounts (6,224) (6,679)
Current maturities of long-term debt (19,526) (23,690)
Long-term debt $ 1,189,436 1,149,614
Line of credit | Revolving credit facility | Secured debt    
Debt Instrument    
Effective interest rate (as a percent) 5.03%  
Long-term debt, gross $ 40,000 0
Line of credit | Term Loan Facility due July 2028 | Secured debt    
Debt Instrument    
Effective interest rate (as a percent) 5.79%  
Long-term debt, gross $ 375,525 375,525
Senior Notes | Senior Notes due December 2027    
Debt Instrument    
Effective interest rate (as a percent) 4.88%  
Long-term debt, gross $ 400,000 400,000
Senior Notes | Senior Notes due September 2032    
Debt Instrument    
Effective interest rate (as a percent) 7.00%  
Long-term debt, gross $ 350,000 350,000
Finance leases and other financing arrangements    
Debt Instrument    
Finance leases and other financing arrangements $ 49,661 $ 54,458
Finance leases and other financing arrangements | Minimum    
Debt Instrument    
Finance lease, rate (as a percent) 1.00%  
Finance leases and other financing arrangements | Maximum    
Debt Instrument    
Finance lease, rate (as a percent) 8.28%  
v3.26.1
Long-Term Debt - Narrative (Details) - USD ($)
 1 Months Ended 3 Months Ended
Sep. 30, 2024
Aug. 31, 2024
Jan. 31, 2024
Mar. 28, 2026
Mar. 29, 2025
Dec. 31, 2025
Mar. 31, 2025
Feb. 29, 2024
Dec. 31, 2017
Debt Instrument                  
Loss on extinguishment and refinancing of debt (Note 10)       $ 0 $ 237,000        
Interest rate cap | Cash flow hedge | Derivatives designated as hedging instruments:                  
Debt Instrument                  
Derivative fixed interest rate (as a percent)               4.50%  
Notional amount               $ 100,000,000.0  
Minimum | Interest rate cap | Cash flow hedge | Derivatives designated as hedging instruments:                  
Debt Instrument                  
Derivative variable interest rate (as a percent)               3.982%  
Minimum | SOFR | Interest rate cap | Cash flow hedge | Derivatives designated as hedging instruments:                  
Debt Instrument                  
Derivative variable interest rate (as a percent)               3.982%  
Maximum | Interest rate cap | Cash flow hedge | Derivatives designated as hedging instruments:                  
Debt Instrument                  
Derivative variable interest rate (as a percent)               3.895%  
Maximum | SOFR | Interest rate cap | Cash flow hedge | Derivatives designated as hedging instruments:                  
Debt Instrument                  
Derivative variable interest rate (as a percent)               3.895%  
Senior Notes                  
Debt Instrument                  
Long-term debt $ 200,000,000.0                
Debt instrument stated interest rate (as a percent) 7.00%                
Pre-tax loss redemption amount $ 500,000                
Letter of credit | Revolving credit facility                  
Debt Instrument                  
Letters of credit       (22,000,000.0)          
Finance leases and other financing arrangements                  
Debt Instrument                  
Finance lease and other financing arrangements       49,661,000   $ 54,458,000      
Senior Note Maturing December 2027 | Senior Notes                  
Debt Instrument                  
Long-term debt       1,220,000,000          
Short-term debt obligation       (19,500,000)          
Senior Note Maturing September 2032 | Senior Notes                  
Debt Instrument                  
Debt instrument face amount   $ 350,000,000.0             $ 400,000,000
Debt instrument stated interest rate (as a percent) 4.63% 7.00%             4.88%
Debt instrument discount rate (as a percent)   1.25%              
Debt issuance costs   $ 5,500,000              
Repayments of debt   $ 150,000,000.0              
Term Loan Facility due July 2028                  
Debt Instrument                  
Unamortized debt issuance costs     $ 800,000            
Term Loan Facility due July 2028 | Minimum | SOFR                  
Debt Instrument                  
Debt instrument, variable rate (as a percent)     1.75%            
Term Loan Facility due July 2028 | Minimum | Corporate credit rating                  
Debt Instrument                  
Debt instrument, variable rate (as a percent)     2.00%            
Term Loan Facility due July 2028 | Maximum | SOFR                  
Debt Instrument                  
Debt instrument, variable rate (as a percent)     2.00%            
Term Loan Facility due July 2028 | Maximum | Corporate credit rating                  
Debt Instrument                  
Debt instrument, variable rate (as a percent)     2.25%            
Term Loan Facility due July 2028 | Term Loan Facility due July 2028                  
Debt Instrument                  
Long-term debt       $ 375,300,000          
Loss on extinguishment and refinancing of debt (Note 10)     $ 1,400,000            
ABL Facility | Revolving credit facility                  
Debt Instrument                  
Line fee (as a percent)       0.25%          
Maximum borrowing capacity             $ 500,000,000.0    
ABL Facility | Letter of credit | Revolving credit facility                  
Debt Instrument                  
Long-term debt       $ 40,000,000.0          
Borrowing availability       $ 259,500,000          
v3.26.1
Income Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Dec. 31, 2025
Income Tax Disclosure [Abstract]      
Effective tax rate (as a percent) (4.60%) (0.30%)  
Income tax expense $ 3,376 $ 618  
Unrecognized tax benefits $ 46,700   $ 47,500
v3.26.1
Segment Information - Narrative (Details)
 3 Months Ended
Mar. 28, 2026
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
v3.26.1
Segment Information - Reportable Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Sep. 27, 2025
Mar. 29, 2025
Segment Reporting Information [Line Items]      
Net revenues $ 722,125   $ 776,006
Adjusted cost of sales 625,968   663,502
Adjusted selling, general and administrative 111,160   113,760
Other segment items (25,698)   (27,437)
Adjusted EBITDA 10,695   26,181
Total Reportable Segment Adjusted EBITDA 10,695   26,181
Depreciation and amortization 29,370   27,295
Interest expense, net 17,203   14,918
Corporate and unallocated costs 4,554   4,312
Net legal and professional expenses and settlements 12,767   11,882
Goodwill impairment 0   137,721
Restructuring and asset-related charges, net 1,979   14,546
M&A related costs, net 7,599   (613)
Net gain on sale of business, property, and equipment     (653)
Loss on extinguishment and refinancing of debt 0   237
Share-based compensation expense 3,682   3,228
Loss, before tax (73,468)   (189,520)
Capital expenditures 26,078   41,954
Segment assets 2,077,268   2,418,915
Operating segments      
Segment Reporting Information [Line Items]      
Net revenues 722,125   776,006
Operating segments | North America      
Segment Reporting Information [Line Items]      
Net revenues 452,713   530,561
Adjusted cost of sales 408,712   465,648
Adjusted selling, general and administrative 58,964   69,499
Other segment items (18,582)   (20,110)
Adjusted EBITDA 3,619   15,524
Depreciation and amortization 18,829   17,325
Goodwill impairment   $ 196,900 137,700
Restructuring and asset-related charges, net 792   10,663
Capital expenditures 15,317   27,736
Segment assets 1,263,792   1,349,336
Operating segments | Europe      
Segment Reporting Information [Line Items]      
Net revenues 269,412   245,445
Adjusted cost of sales 217,256   197,854
Adjusted selling, general and administrative 52,196   44,261
Other segment items (7,116)   (7,327)
Adjusted EBITDA 7,076   10,657
Depreciation and amortization 8,384   7,565
Restructuring and asset-related charges, net 1,154   3,147
Capital expenditures 9,824   10,290
Segment assets 683,981   774,988
Intersegment Eliminations      
Segment Reporting Information [Line Items]      
Net revenues 0   522
Intersegment Eliminations | North America      
Segment Reporting Information [Line Items]      
Net revenues 0   33
Intersegment Eliminations | Europe      
Segment Reporting Information [Line Items]      
Net revenues 0   489
Corporate and reconciling items      
Segment Reporting Information [Line Items]      
Net revenues 722,125   776,528
Corporate and reconciling items | North America      
Segment Reporting Information [Line Items]      
Net revenues 452,713   530,594
Corporate and reconciling items | Europe      
Segment Reporting Information [Line Items]      
Net revenues 269,412   245,934
Corporate and Unallocated Costs      
Segment Reporting Information [Line Items]      
Depreciation and amortization 2,157   2,405
Restructuring and asset-related charges, net 33   736
Other special items 7,009   2,828
Capital expenditures 937   3,928
Segment assets 129,495   $ 294,591
Environmental matter costs $ 3,100    
v3.26.1
Capital Stock (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Dec. 31, 2025
Jul. 28, 2022
Jul. 27, 2022
Equity [Abstract]          
Shares held in employee trust (in shares) 193,941   193,941    
Shares held in employee trust $ 12.4   $ 12.4    
Share authorized for repurchase $ 175.7     $ 200.0 $ 400.0
Common shares repurchased (in shares) 0 0      
v3.26.1
Loss Per Share - Basic and Diluted Loss Per Share Calculations (Details) - shares
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Earnings Per Share [Abstract]    
Weighted average outstanding shares of common stock basic (in shares) 85,803,503 84,917,294
Restricted stock units, performance share units and options to purchase common stock (in shares) 0 0
Weighted average outstanding shares of common stock diluted (in shares) 85,803,503 84,917,294
v3.26.1
Loss Per Share - Potentially Dilutive Securities (Details) - shares
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Common Stock options    
Incremental Weighted Average Shares Attributable to Dilutive Effect    
Antidilutive securities excluded from computation of diluted earnings per share (in shares) 1,289,560 1,558,883
Restricted stock units    
Incremental Weighted Average Shares Attributable to Dilutive Effect    
Antidilutive securities excluded from computation of diluted earnings per share (in shares) 2,295,706 1,205,152
Performance share units    
Incremental Weighted Average Shares Attributable to Dilutive Effect    
Antidilutive securities excluded from computation of diluted earnings per share (in shares) 573,306 64,781
v3.26.1
Share-Based Compensation - Activity (Details) - $ / shares
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Shares    
Options granted (in shares) 0 536,432
Options cancelled (in shares) 5,568 41,989
Weighted Average Exercise Price Per Share    
Options granted (usd per share) $ 0 $ 9.05
Options cancelled (usd per share) $ 33.34 $ 22.28
Weighted Average Grant-Date Fair Value Per Share    
Equity instrument performance adjustment (in shares) (181,281) 0
Equity instrument performance adjustment, weighted average grant date fair value (usd per share) $ 0 $ 0
RSUs    
Weighted Average Grant-Date Fair Value Per Share    
Equity instruments granted (in shares) 1,150,708 1,386,301
Equity instruments granted, weighted average exercise price (usd per share) $ 2.72 $ 9.02
PSU's    
Weighted Average Grant-Date Fair Value Per Share    
Equity instruments granted (in shares) 0 620,673
Equity instruments granted, weighted average exercise price (usd per share) $ 0 $ 9.47
v3.26.1
Share-Based Compensation - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Share-based Compensation Arrangement by Share-based Payment Award    
Stock-based compensation $ 3.7 $ 3.2
Performance share units    
Share-based Compensation Arrangement by Share-based Payment Award    
Stock compensation not yet recognized $ 12.7  
Recognition period for stock compensation not yet recognized (in years) 1 year 6 months  
v3.26.1
Restructuring and Asset-Related Charges, Net - Impairment by Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Restructuring Cost and Reserve    
Restructuring severance and employee-related charges, net $ 570 $ 12,605
Other restructuring associated costs, net 1,313 1,775
Asset-related charges, net 96 166
Other restructuring associated costs and asset-related charges, net 1,409 1,941
Total restructuring and asset-related charges, net 1,979 14,546
Operating segments | North America    
Restructuring Cost and Reserve    
Restructuring severance and employee-related charges, net 456 10,019
Other restructuring associated costs, net 336 644
Asset-related charges, net 0 0
Other restructuring associated costs and asset-related charges, net 336 644
Total restructuring and asset-related charges, net 792 10,663
Operating segments | Europe    
Restructuring Cost and Reserve    
Restructuring severance and employee-related charges, net 81 1,850
Other restructuring associated costs, net 977 1,131
Asset-related charges, net 96 166
Other restructuring associated costs and asset-related charges, net 1,073 1,297
Total restructuring and asset-related charges, net 1,154 3,147
Corporate and Unallocated Costs    
Restructuring Cost and Reserve    
Restructuring severance and employee-related charges, net 33 736
Other restructuring associated costs, net 0 0
Asset-related charges, net 0 0
Other restructuring associated costs and asset-related charges, net 0 0
Total restructuring and asset-related charges, net $ 33 736
Restructuring and asset-related charges, net   $ 700
v3.26.1
Restructuring and Asset-Related Charges, Net - Restructuring Accrual (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Restructuring Reserve    
Restructuring reserve, beginning balance $ 9,003 $ 7,605
Current period charges, net 1,884 41,362
Payments (7,096) (40,508)
Currency translation (52) 544
Restructuring reserve, ending balance $ 3,739 $ 9,003
v3.26.1
Restructuring and Asset-Related Charges, Net - Narrative (Details) - USD ($)
$ in Thousands
Mar. 28, 2026
Dec. 31, 2025
Mar. 29, 2025
Dec. 31, 2024
Restructuring Cost and Reserve        
Restructuring accrual (Note 20) $ 3,739 $ 9,003 $ 9,003 $ 7,605
European Operation Transformation        
Restructuring Cost and Reserve        
Restructuring accrual (Note 20) 2,300      
Restructuring and related cost, expected cost remaining 5,500      
North American Initiatives        
Restructuring Cost and Reserve        
Restructuring accrual (Note 20) 1,200      
Restructuring and related cost, expected cost remaining $ 7,500      
v3.26.1
Restructuring and Asset-Related Charges, Net - Costs and Cash Outlays (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Restructuring Cost and Reserve    
Total cash outlays $ 7,096 $ 40,508
Sales    
Restructuring Cost and Reserve    
Total cash outlays 5,500  
Debt repayment for financed equipment 900  
Manufacturing Facility Closure Plan    
Restructuring Cost and Reserve    
Restructuring expected cost 95,200  
Cost incurred to date 87,583  
Restructuring costs 710 11,918
Total cash outlays 67,600  
Cumulative costs 60,092  
Total cash outlays 3,422 5,556
Manufacturing Facility Closure Plan | Total cash charges    
Restructuring Cost and Reserve    
Restructuring expected cost 61,000  
Cost incurred to date 54,548  
Restructuring costs 792 10,797
Manufacturing Facility Closure Plan | Restructuring severance and employee-related charges    
Restructuring Cost and Reserve    
Restructuring expected cost 36,600  
Cost incurred to date 35,009  
Restructuring costs 456 10,019
Manufacturing Facility Closure Plan | Other restructuring associated costs    
Restructuring Cost and Reserve    
Restructuring expected cost 17,700  
Cost incurred to date 12,820  
Restructuring costs 336 644
Manufacturing Facility Closure Plan | Product-related cash charges    
Restructuring Cost and Reserve    
Restructuring expected cost 6,700  
Cost incurred to date 6,719  
Restructuring costs 0 134
Manufacturing Facility Closure Plan | Total non-cash charges    
Restructuring Cost and Reserve    
Restructuring expected cost 34,200  
Cost incurred to date 33,035  
Restructuring costs (82) 1,121
Manufacturing Facility Closure Plan | Asset-related charges    
Restructuring Cost and Reserve    
Restructuring expected cost 24,900  
Cost incurred to date 23,974  
Restructuring costs 0 0
Manufacturing Facility Closure Plan | Inventory and other product-related non-cash charges    
Restructuring Cost and Reserve    
Restructuring expected cost 9,300  
Cost incurred to date 9,061  
Restructuring costs (82) 1,121
European Operation Transformation    
Restructuring Cost and Reserve    
Restructuring expected cost 51,700  
Cost incurred to date 47,555  
Restructuring costs 1,154 3,147
Total cash outlays 49,000  
Cumulative costs 43,570  
Total cash outlays 2,843 4,600
European Operation Transformation | Total cash charges    
Restructuring Cost and Reserve    
Restructuring expected cost 49,000  
Cost incurred to date 45,675  
Restructuring costs 1,058 2,981
European Operation Transformation | Restructuring severance and employee-related charges    
Restructuring Cost and Reserve    
Restructuring expected cost 32,000  
Cost incurred to date 30,969  
Restructuring costs 81 1,850
European Operation Transformation | Other restructuring associated costs    
Restructuring Cost and Reserve    
Restructuring expected cost 17,000  
Cost incurred to date 14,706  
Restructuring costs 977 1,131
European Operation Transformation | Asset-related charges    
Restructuring Cost and Reserve    
Restructuring expected cost 2,700  
Cost incurred to date 1,880  
Restructuring costs $ 96 $ 166
v3.26.1
Other Expense (Income) (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Other Income and Expenses [Abstract]    
Foreign currency losses (gains), net $ 1,075 $ (209)
Pension expense 494 867
Governmental assistance (5) (3)
Cash received on real estate investment 0 (7,567)
Income from refund of deposits for China antidumping and countervailing duties, net 0 (2,859)
Gains on commodity derivatives 0 (361)
Other items, net (521) (454)
Total other expense (income) $ 1,043 $ (10,586)
v3.26.1
Derivative Financial Instruments - Narrative (Details) - USD ($)
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Feb. 29, 2024
Derivatives, Fair Value [Line Items]      
Gain (loss) on derivative $ (1,265,000) $ (309,000)  
(Loss) gain on pre tax market to market $ 0 (149,000)  
Derivative, gain (loss), statement of income or comprehensive income [extensible enumeration] Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax    
Foreign exchange, forecasted transactions | Derivatives not designated as hedging instruments:      
Derivatives, Fair Value [Line Items]      
Notional $ 309,200,000    
Foreign exchange, forecasted transactions | Derivatives designated as hedging instruments: | Cash flow hedge | Minimum      
Derivatives, Fair Value [Line Items]      
Gain (loss) on derivative   (1,600,000)  
Foreign exchange, forecasted transactions | Derivatives designated as hedging instruments: | Cash flow hedge | Maximum      
Derivatives, Fair Value [Line Items]      
Gain (loss) on derivative   200,000  
Commodity contract | Derivatives designated as hedging instruments: | Cash flow hedge      
Derivatives, Fair Value [Line Items]      
AOCI, cash flow hedge cumulative gain (loss), after tax 0    
Interest rate cap | Derivatives designated as hedging instruments: | Cash flow hedge      
Derivatives, Fair Value [Line Items]      
Gain (loss) on derivative   $ (200,000)  
AOCI, cash flow hedge cumulative gain (loss), after tax $ 0    
Derivative fixed interest rate (as a percent)     4.50%
Notional amount     $ 100,000,000.0
Interest rate cap | Derivatives designated as hedging instruments: | Cash flow hedge | Minimum      
Derivatives, Fair Value [Line Items]      
Derivative variable interest rate (as a percent)     3.982%
Interest rate cap | Derivatives designated as hedging instruments: | Cash flow hedge | Maximum      
Derivatives, Fair Value [Line Items]      
Derivative variable interest rate (as a percent)     3.895%
v3.26.1
Derivative Financial Instruments - Fair Values Of Derivative Instruments (Details) - USD ($)
$ in Thousands
Mar. 28, 2026
Dec. 31, 2025
Other current assets | Foreign currency forward contracts | Derivatives not designated as hedging instruments:    
Derivative Asset, Fair Value, Amount Not Offset Against Collateral    
Derivative Assets $ 442 $ 539
Accrued expenses and other current liabilities | Foreign currency forward contracts | Derivatives not designated as hedging instruments:    
Derivative Asset, Fair Value, Amount Not Offset Against Collateral    
Derivative Liabilities 783 583
Accrued expenses and other current liabilities | Interest rate contracts | Derivatives designated as hedging instruments:    
Derivative Asset, Fair Value, Amount Not Offset Against Collateral    
Derivative Liabilities $ 0 $ 41
v3.26.1
Derivative Financial Instruments - Gain (Loss) on Derivative (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Derivative [Line Items]    
Amount of (Loss) Gain Recognized in Earnings on Derivatives $ (1,265) $ (309)
Foreign currency forward contracts | Derivatives designated as hedging instruments:    
Derivative [Line Items]    
Amount of (Loss) Gain Recognized in Earnings on Derivatives (106) 47
Foreign currency forward contracts | Derivatives not designated as hedging instruments:    
Derivative [Line Items]    
Amount of (Loss) Gain Recognized in Earnings on Derivatives (1,120) (752)
Commodity contracts | Derivatives designated as hedging instruments:    
Derivative [Line Items]    
Amount of (Loss) Gain Recognized in Earnings on Derivatives 0 35
Commodity contracts | Derivatives not designated as hedging instruments:    
Derivative [Line Items]    
Amount of (Loss) Gain Recognized in Earnings on Derivatives 0 361
Interest rate contracts | Derivatives designated as hedging instruments:    
Derivative [Line Items]    
Amount of (Loss) Gain Recognized in Earnings on Derivatives $ (39) $ 0
v3.26.1
Fair Value of Financial Instruments (Details) - USD ($)
$ in Thousands
Mar. 28, 2026
Dec. 31, 2025
Liabilities:    
Derivative liability, current, statement of financial position [Extensible Enumeration] Accrued expenses and other current liabilities (Note 8) Accrued expenses and other current liabilities (Note 8)
Derivative liabilities, recorded in accrued expenses and other current liabilities $ 783 $ 624
Carrying Amount    
Assets:    
Cash equivalents 18,268 65,386
Derivative assets, recorded in other current assets $ 442 $ 539
Derivative asset, current, statement of financial position [Extensible Enumeration] Other current assets Other current assets
Deferred compensation plan assets, recorded in other assets $ 5,163 $ 5,773
Liabilities:    
Debt, recorded in long-term debt and current maturities of long-term debt 1,215,186 1,179,983
Derivative liabilities, recorded in accrued expenses and other current liabilities 783 624
Deferred compensation plan liabilities, recorded in deferred credits and other liabilities 5,170 5,778
Total Fair Value    
Assets:    
Cash equivalents 18,268 65,386
Derivative assets, recorded in other current assets 442 539
Deferred compensation plan assets, recorded in other assets 5,163 5,773
Liabilities:    
Debt, recorded in long-term debt and current maturities of long-term debt 843,673 974,915
Derivative liabilities, recorded in accrued expenses and other current liabilities 783 624
Deferred compensation plan liabilities, recorded in deferred credits and other liabilities 5,170 5,778
Total Fair Value | Level 1    
Assets:    
Cash equivalents 18,268 65,386
Derivative assets, recorded in other current assets 0 0
Deferred compensation plan assets, recorded in other assets 0 0
Liabilities:    
Debt, recorded in long-term debt and current maturities of long-term debt 0 0
Derivative liabilities, recorded in accrued expenses and other current liabilities 0 0
Deferred compensation plan liabilities, recorded in deferred credits and other liabilities 0 0
Total Fair Value | Level 2    
Assets:    
Cash equivalents 0 0
Derivative assets, recorded in other current assets 442 539
Deferred compensation plan assets, recorded in other assets 5,163 5,773
Liabilities:    
Debt, recorded in long-term debt and current maturities of long-term debt 843,673 974,915
Derivative liabilities, recorded in accrued expenses and other current liabilities 783 624
Deferred compensation plan liabilities, recorded in deferred credits and other liabilities 5,170 5,778
Total Fair Value | Level 3    
Assets:    
Cash equivalents 0 0
Derivative assets, recorded in other current assets 0 0
Deferred compensation plan assets, recorded in other assets 0 0
Liabilities:    
Debt, recorded in long-term debt and current maturities of long-term debt 0 0
Derivative liabilities, recorded in accrued expenses and other current liabilities 0 0
Deferred compensation plan liabilities, recorded in deferred credits and other liabilities 0 0
Total Fair Value | Assets measured at NAV    
Assets:    
Cash equivalents 0 0
Derivative assets, recorded in other current assets 0 0
Deferred compensation plan assets, recorded in other assets 0 0
Liabilities:    
Debt, recorded in long-term debt and current maturities of long-term debt 0 0
Derivative liabilities, recorded in accrued expenses and other current liabilities 0 0
Deferred compensation plan liabilities, recorded in deferred credits and other liabilities $ 0 $ 0
v3.26.1
Commitments and Contingencies (Details) - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Oct. 25, 2024
Nov. 03, 2021
Feb. 18, 2021
Nov. 19, 2019
Apr. 12, 2019
Mar. 13, 2019
May 11, 2018
Dec. 31, 2025
Feb. 28, 2018
Mar. 28, 2026
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2021
Loss Contingencies                          
Accrued self-insurance liability               $ 76.0   $ 73.9 $ 76.0    
Financing bonds and letters of credit               $ 74.5   $ 75.0 $ 74.5    
Environmental loss contingency, current, statement of financial position [Extensible Enumeration]               Accrued expenses and other current liabilities (Note 8)   Accrued expenses and other current liabilities (Note 8) Accrued expenses and other current liabilities (Note 8)    
Environmental loss contingencies, current               $ 7.6   $ 7.5 $ 7.6    
Environmental loss contingency, noncurrent, statement of financial position [Extensible Enumeration]               Deferred credits and other liabilities   Deferred credits and other liabilities Deferred credits and other liabilities    
Environmental loss contingencies, non-current               $ 13.4   $ 13.4 $ 13.4    
Preferred remedial alternatives totaling                         $ 23.4
Remediation cost outcome                       $ 11.8  
Remediation cost, estimated amount               21.0          
Long term receivable, amount               5.6     5.6    
Minimum                          
Loss Contingencies                          
Environmental remedial feasibility alternative                         11.8
Remediation cost outcome               17.4       17.4  
Minimum | Domestic Product Liability                          
Loss Contingencies                          
Concentration risk, auto, employee and general liability                   5.0      
Minimum | Auto, General Liability, Personal Injury and Workers Compensation                          
Loss Contingencies                          
Concentration risk, auto, employee and general liability                   3.0      
Maximum                          
Loss Contingencies                          
Environmental remedial feasibility alternative                         $ 33.4
Remediation cost outcome               $ 33.6       $ 33.6  
Maximum | Domestic Product Liability                          
Loss Contingencies                          
Concentration risk, auto, employee and general liability                   200.0      
Maximum | Auto, General Liability, Personal Injury and Workers Compensation                          
Loss Contingencies                          
Concentration risk, auto, employee and general liability                   200.0      
Steve and Sons                          
Loss Contingencies                          
Damages awarded to plaintiff     $ 36.5 $ 7.1   $ 36.5              
Settlement proceeds awarded $ 115.0           $ 1.2            
Damages sought     $ 139.4                    
Litigation settlement, expense                   $ 8.5      
Steve and Sons | Attorney Fees                          
Loss Contingencies                          
Damages sought         $ 28.4                
Steve and Sons | Legal Cost                          
Loss Contingencies                          
Damages sought         $ 1.7                
Anti-dumping and countervailing duty investigation                          
Loss Contingencies                          
Damages awarded to plaintiff                     $ 2.1    
Past Damages | Steve and Sons                          
Loss Contingencies                          
Damages awarded to plaintiff           9.9     $ 12.2        
Future Damages | Steve and Sons                          
Loss Contingencies                          
Damages awarded to plaintiff           $ 139.4     $ 46.5        
Loss contingency accrual, payments   $ 66.4                      
v3.26.1
Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Cash Operating Activities:    
Operating leases $ 15,829 $ 12,403
Interest payments on financing lease obligations 184 194
Cash paid for amounts included in the measurement of lease liabilities 16,013 12,597
Cash Investing Activities:    
Purchases of securities for deferred compensation plan (174) (273)
Change in securities for deferred compensation plan (174) (273)
Cash received on notes receivable 5 7
Change in notes receivable 5 7
Non-cash Investing Activities:    
Property, equipment and intangibles purchased in accounts payable 3,599 7,417
Property, equipment and intangibles purchased with debt 3,081 2,653
Customer accounts receivable converted to notes receivable 289 3
Cash Financing Activities:    
Borrowings on long-term debt 74,004 0
Payments of long-term debt (41,692) (5,254)
Payments of debt issuance and extinguishment costs, including underwriting fees 0 (810)
Change in long-term debt and payments of debt extinguishment costs 32,312 (6,064)
Cash paid for amounts included in the measurement of finance lease liabilities 867 284
Non-cash Financing Activities:    
Debt issuance costs in accounts payable 0 245
Shares surrendered for tax obligations for employee share-based transactions in accrued liabilities 23 623
Reclassification of share-based awards to liability in accrued liabilities 90 0
Other Supplemental Cash Flow Information:    
Cash taxes paid, net of refunds 3,570 8,805
Cash interest paid $ 16,599 $ 17,209